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Abstract 
Development and Characterization of UHMWPE Fiber-Reinforced 
Hydrogels for Meniscal Replacement 
Julianne Leigh Holloway 
Anthony M. Lowman, Ph.D., and Giuseppe R. Palmese, Ph.D. 
 
 
 
 
Meniscal tears are the most common orthopedic injuries to the human body. The current 
treatment of choice, however, is a partial meniscectomy that leads to osteoarthritis 
proportional to the amount of tissue removed. As a result, there is a significant clinical 
need to develop materials capable of restoring the biomechanical contact stress 
distribution to the knee after meniscectomy and preventing the onset of osteoarthritis. In 
this work, a fiber-reinforced hydrogel-based synthetic meniscus was developed that 
allows for tailoring of the mechanical properties and molding of the implant to match the 
size, shape, and property distribution of the native tissue. 
 
Physically cross-linked poly(vinyl alcohol) (PVA) hydrogels were reinforced with ultra-
high molecular weight polyethylene (UHMWPE) fibers and characterized in compression 
(0.1 - 0.8 MPa) and tension (0.1 - 250 MPa) showing fine control over mechanical 
properties within the range of the human meniscus. Morphology and crystallinity analysis 
of PVA hydrogels showed increases in crystallinity and PVA densification, or phase 
separation, with freeze-thaw cycles. A comparison of freeze-thawed and aged, physically 
cross-linked hydrogels provided insight on both crystallinity and phase separation as 
mechanisms for PVA gelation. Results indicated both mechanisms independently 
contributed to hydrogel modulus for freeze-thawed hydrogels.  
 xviii 
 
In vitro swelling studies were performed using osmotic solutions to replicate the swelling 
pressure present in the knee. Minimal swelling was observed for hydrogels with a PVA 
concentration of 30-35 wt%, independently of hydrogel freeze-thaw cycles. This allows 
for independent tailoring of hydrogel modulus and pore structure using freeze-thaw 
cycles and swelling behavior using polymer concentration to match a wide range of 
properties needed for various soft tissue applications.  
 
The UHMWPE-PVA interface was identified as a significant weakness. To improve 
interfacial adhesion, a novel biocompatible PVA grafting technique was developed to 
form a direct covalent linkage at the fiber-matrix interface. Chemical grafting was 
tailored as a function of the number of sites available for covalent bonding and the 
percentage of sites reacted. PVA grafting resulted in significant improvements to 
interfacial shear strength from 11 kPa without any treatment to above 220 kPa following 
grafting. After grafting, failure was observed cohesively within the PVA hydrogel 
indicating the UHMWPE-PVA interface was successfully optimized.  
 
Lastly, in vitro gait simulations and an in vivo sheep study demonstrated the feasibility 
and biocompatibility of the proposed UHMWPE-PVA composite. The results from this 
work can be applied to designing materials for other soft tissue applications, including the 
anterior cruciate ligament (ACL) and the annulus fibrosus.  
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Chapter 1: Introduction 
 
The meniscus is a crescent-shaped fibrocartilage disc present in the knee important for 
weight bearing and shock absorption [1-3]. The biomechanical functions of the meniscus 
stem from its chemical and physical composition and structure. The high tensile 
properties are derived from a complex network of collagen fibers. In particular, strong 
type I collagen fibers are arranged circumferentially in bundles throughout the meniscus 
and withstand the high hoop stresses that occur during gait [2,4,5]. Depending on the 
region tested, the tensile modulus for a human meniscus can vary from 2 to 295 MPa, 
which reflects the anisotropic nature of the collagen fibers and their arrangement [6]. 
Injuries to the meniscus are the most common injuries requiring surgical intervention in 
orthopedic practice [7] with approximately one million surgeries occurring in the United 
States every year [8]. Most injuries occur in the inner two-thirds of the meniscus, which 
is avascular and generally not surgically repairable.  
 
Initially, the meniscus was regarded as an unnecessary appendage and was completely 
removed at the first sign of injury [3]. In the past several decades, however, total and 
partial meniscectomy has been shown to lead to severe joint degeneration [9,10]. 
Changes in the contact pressure distributions after removal of the meniscus have been 
suggested to lead to osteoarthritis proportional in severity to the amount of tissue 
removed [8]. Today, partial meniscectomy remains the most common treatment for a 
meniscal injury, as well as the most commonly performed surgery in orthopedics [7]. 
Meniscal allograft transplantation is FDA approved and is capable of alleviating pain and 
 2 
swelling. Worldwide use in the clinic remains low, however, due to variable results, 
availability, donor matching, the possibility of transferring diseases, and cost [1,3,11]. As 
such, there is a clinical need to develop materials capable of restoring the native contact 
pressure distributions during gait within the knee and preventing the onset of 
osteoarthritis.  
 
Current research focuses on regenerating meniscal tissue using tissue engineering [12-15]. 
Tissue-engineered degradable scaffolds show promise; although, poor mechanical 
properties limit the use of scaffolds as total meniscal replacements [1]. Limited research 
has been performed on the development of a permanent synthetic meniscus. A polymer 
based, synthetic meniscus can overcome a majority of current issues by allowing the 
tailoring of mechanical properties, as well as molding of the prosthesis to the size and 
shape of the native cartilage. The selection of biomaterials to use for the implant, 
however, has shown to be a significant issue [1].  
 
The native meniscus is a biologic composite of reinforcing collagen fibers and 
extracellular matrix. As a result, synthetic fiber-reinforced composite materials are an 
obvious material choice to replicate the property distribution within the native meniscus. 
The proposed biomaterial seeks to replicate the anisotropic property distribution of the 
human meniscus using a novel fiber-hydrogel composite material in order to restore 
native contact pressures. Mimicking the mechanical property distribution of the meniscus 
is essential for restoring the contact pressures along the tibial plateau during gait, and 
preventing the onset of osteoarthritis following injury. Toward this purpose, the objective 
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of this work was to design a novel composite material that combines a soft poly(vinyl 
alcohol) (PVA) hydrogel capable of replicating the compressive properties of the 
meniscus and strong ultra high molecular weight polyethylene (UHMWPE) fibers 
capable of resisting the hoop stresses that occur circumferentially within the meniscus. 
Physically cross-linked PVA hydrogels are extremely biocompatible [16], possess similar 
viscoelastic properties compared to articular [17,18] and meniscal cartilage [19], and do 
not exhibit any wear even after millions of cycles [20]. UHMWPE fibers are also very 
biocompatible and possess the high strength and tensile modulus needed within the 
meniscus and for fixation of the implant [21,22]. 
 
In this work, the material properties and gelation mechanism for physically cross-linked 
PVA hydrogels were determined. The swelling behavior was also evaluated using 
osmotic pressure solutions to mimic the high swelling pressure present in load-bearing 
joints. Due to the hydrophobic/hydrophilic mismatch between UHMWPE fibers and PVA 
hydrogels, the fiber-matrix interface was identified as a significant weakness. A novel 
grafting technique was developed to create a covalent linkage at the UHMWPE-PVA 
interface to improve adhesion. Finally, the feasibility and biocompatibility of this implant 
was evaluated in vitro using a knee gait simulator and in vivo using a sheep model. 
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Chapter 2: Background 
 
2.1. Anatomy of the knee joint 
The knee joint, shown in Figure 2.1, is typically considered to contain both the 
tibiofemoral and the patellofemoral joints [1]. The tibiofemoral joint is located where the 
tibia (shin bone) and the femur (thigh bone) articulate. The patellofemoral joint, likewise, 
is located where the patella (knee cap) and the femur join. The fibula (calf bone) is not 
involved during articulation and is connected to the tibia below the knee [2].  
 
The tibiofemoral joint is the largest joint in the body [3]. In the tibiofemoral joint, the size 
and shape of the lateral and medial femoral condyles correspond to the shape of the tibial 
plateau. Together, the unique bone structure of the tibia and femur provide stability 
during gait [2]. The patella is a sesamoid bone located in the quadriceps tendon. The 
patella’s primary functions are to provide protection to the anterior surface of the knee 
joint and additional leverage during extension [3].  
 
The knee is composed of four main ligaments that provide stability during gait: the 
anterior cruciate ligament (ACL), the posterior cruciate ligament (PCL), the medial 
collateral ligament (MCL), and the lateral collateral ligament (LCL). These ligaments are 
extremely important in providing stability to the knee and in guiding and limiting joint 
motion [4]. The ACL is particularly important during extension, preventing 
hyperextension. Similarly, the PCL is important during flexion, preventing hyperflexion. 
Both cruciate ligaments are important for preventing internal and external rotation during 
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joint articulation [5].  
 
Hyaline articular cartilage covers the articulating surfaces of the femur and the tibia, 
primarily the femoral condyles and the tibial plateau. Articular cartilage provides 
lubrication to reduce friction and protects the bone surfaces during joint articulation. 
During gait, cartilage also absorbs and distributes mechanical loads along the entire area 
of bone it covers [6,7].  
 
The meniscus is a crescent-shaped fibrocartilage disc present in both the medial and 
lateral compartments of the knee between the femur and the tibia, as shown in Figure 2.2 
[8]. The meniscus is held in place by fixation at the posterior and anterior horns of the 
meniscus through insertional ligaments into the tibial plateau and attachment to the joint 
capsule along the peripheral rim of the meniscus [9]. During gait, the meniscus is 
primarily responsible for distributing load across the tibial plateau by increasing the 
contact area between the femur and tibia. Additionally, these tissues are known to 
contribute to joint stability, lubrication, and shock absorption [10].  
 
2.2. Meniscus  
2.2.1. Structure and biology 
The meniscus is a relatively avascular structure. Blood vessels only permeate the outer 
10-30% of the meniscus [11]. As a result, a majority of the meniscus derives nutrients 
from either diffusion or mechanical pumping during load bearing [12]. Similarly, 
innervation is most prominent at horn fixation sites with little and conflicting evidence of 
 8 
innervation in the inner third of the meniscus [9,13,14]. 
 
There are three different cell types within the meniscus: fibrochondrocytes, fibroblast-
like cells, and superficial zone cells. Fibrochondrocytes make up a majority of the cells 
and are located primarily within the inner half of the meniscus. Fibrochondrocytes differ 
from chondrocytes, articular cartilage cells, as they produce primarily type I fibrillar 
collagen instead of type II. Fibroblast-like cells are located on the outer periphery of the 
meniscus, where the tissue is more fibrous in nature. Superficial zone cells are located on 
the surface of the meniscus and interact with synovial fluid [15]. 
 
The biochemical composition of the meniscus consists primarily of water, approximately 
60-70 wt% [16]. On a dry weight basis, the meniscus contains mostly collagen, 60-80%, 
where over 80% is type I [17]. Collagen type I fibrils are approximately 50 nm in 
diameter and are stronger than steel on a per weight basis [18]. Collagen type II, the main 
collagen in articular cartilage, has a smaller diameter and is weaker in comparison [12]. 
The specific orientation of the collagen fibers within the meniscus has been researched 
extensively and found to contribute directly to the tensile properties observed [12,19-22]. 
At the surface of the meniscus, type II collagen fibers form a random woven mesh. 
Immediately under this layer, stronger type I collagen fibers are arranged 
circumferentially in bundles to withstand the hoop stresses that occur during gait. Fibers 
may also be found in the radial direction and can serve as tie fibers between 
circumferential bundles to prevent longitudinal tearing. A schematic representation of the 
complex collagen fiber network is shown in Figure 2.3 [23].  
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Noncollagenous proteins contribute approximately 8-13% to meniscal dry weight [24]. 
Most importantly, the meniscus contains approximately 1-2% proteoglycans by dry 
weight, primarily in the form of chondroitin sulfate [12,17]. The presence of 
proteoglycans within the meniscus contributes to the compressive properties observed. 
Proteoglycans are large, negatively charged molecules that resist compressive loads as a 
result of the charge-charge resistive force, as well as the osmotic pressure, or swelling 
pressure, that results from the attraction of positive counter ions [6]. The presence of a 
high osmotic pressure is known to influence the hydration of tissues present within load-
bearing joints [25]. The swelling pressure of tissues within the hip and knee are between 
0.3 and 2.5 atm, and reach as high as 3.5 atm for the intervertebral disk [26,27]. A table 
comparing the biochemical composition of the meniscus to other soft tissues is shown in 
Table 2.1.  
 
2.2.2. Biomechanics  
During normal use, the forces exerted on the knee have been calculated to be 3.5 times 
bodyweight, compared to 1.5, 2.5, and 3.3 for the shoulder, ankle, and hip joints 
respectively [42]. The primary function of the meniscus is to redistribute load from the 
femur along the tibial plateau. During loading, the meniscus is subjected to an axial 
compressive force that is distributed over the area that the meniscus is in contact with the 
tibia. With increased force, the meniscus will extrude radially out of the joint due to its 
wedge shaped cross-section. Extrusion is prevented by the circumferential arrangement 
of type I collagen fibers throughout the meniscus and the fibrous insertional ligaments at 
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the meniscal horns. Through this mechanism circumferential, or hoop, stresses are 
formed that resist radial displacement [43]. Figure 2.4 summarizes the forces on the 
meniscus during loading [44].  
 
Additional biomechanical functions of the meniscus include shock absorption, lubrication, 
and stabilization [12,43,45,46]. The water content and viscoelastic behavior of the 
meniscus is believed to facilitate the meniscus’ role as a shock absorber. Shock 
absorption is reported to be approximately 20% less in knees without a meniscus, where 
shock absorption was measured by quantifying the loss of intensity (attenuation) in the 
shock waves generated following a heel strike between the tibia and the femur [47]. 
Although the menisci are not the primary stabilizers in the knee, in an ACL-deficient 
knee, it is well known meniscal injuries significantly increase anterior translation and 
decrease knee stability [48]. Wang and Walker also indicate the importance of the 
meniscus in limiting tibial internal-external rotation [49].   
 
Depending on the region tested, the tensile modulus for a human meniscus can vary from 
2 to 295 MPa, which reflects the inhomogeneity and anisotropic nature of the collagen 
fibers and their arrangement [17]. In the radial direction, perpendicular to the 
circumferential collagen bundles, Tissakht and Ahmed reported a tensile modulus in the 
range between 2 to 23 MPa [50]. A much higher tensile modulus range was reported in 
the direction of the circumferential collagen fiber bundles, 94 to 295 MPa [51]. The 
tensile strength of the meniscus is reported to range from 0.5 to 10 MPa, with a similar 
dependence on collagen fiber orientation as tensile modulus [22]. 
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The compressive modulus of the human meniscus is fairly uniform throughout the tissue 
and reflects the presence of proteoglycans. A study performed by Joshi et al. using 
biphasic theory reported the aggregate compressive modulus of the human meniscus as 
0.22 MPa [52]. A summary of the mechanical properties of the meniscus in comparison 
to other soft tissues is shown in Table 2.2.  
 
2.3. Meniscal injuries 
Injuries to the meniscus are the most common injuries requiring surgical intervention in 
orthopedic practice [59] with approximately one million surgeries occurring in the United 
States every year [60]. There are two types of meniscal tears: traumatic and degenerative. 
Traumatic tears occur in young, active individuals as a result of any particular stress 
exceeding the strength of the meniscus [12, 61]. Over 180,000 young Americans suffer 
from traumatic tears every year [12]. Degenerative tears occur in older individuals as the 
tissue in the knee joint begins to degrade. Meniscal degeneration begins at the age of 30 
and occurs in both men and women, as well as in both active and inactive individuals. It 
should be noted that degenerative tears typically do not have the same healing potential 
as traumatic tears [12].  
 
Meniscal tears are classified based on length, depth, and location of the tear [62]. 
Location is particularly important, as only tears that occur in the vascular section of the 
meniscus are capable of healing. The degree of vascularization within the meniscus 
varies and can be as low as 10% and as high as 30% [11]. The tear’s location is classified 
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using the zones shown in Figure 2.5 [63]. Tears occurring in the red zone (outer third of 
the meniscus) have the highest potential for healing, limited potential in the red-white 
(middle third of the meniscus), and no healing potential in the inner third (white zone). 
 
2.4. Current treatments 
For many years the meniscus was considered an unnecessary appendage and was 
completely removed at any sign of injury [45]. In fact, an article published in the British 
Journal of Surgery by McMurray in 1942 [64] states:  
“When the knee-joint is opened on the anterior aspect, and the suspected 
cartilage appears normal, its removal can be undertaken with confidence if 
the diagnosis of a posterior tear has been arrived at prior to operation. A 
far too common error is shown in the incomplete removal of the injured 
meniscus.”  
 
The consequences following meniscectomy were not reported until 1948 when Fairbank 
performed a radiographic analysis on 107 patients post meniscectomy. Observed changes 
included: joint space narrowing between the femur and tibia, femoral condyle flattening, 
and ridge formation following meniscectomy. Fairbank [65] concludes:  
“Investigations suggest that these changes are due to loss of the weight-
bearing function of the meniscus. Meniscectomy is not wholly innocuous; 
it interferes, at least temporarily, with the mechanics of the joint. It seems 
likely that narrowing of the joint space will predispose to early 
degenerative changes.”  
 
Today, the consequences of a meniscectomy are well documented [65-72] and care is 
taken to be as conservative as possible regarding tissue removal. As discussed previously, 
tears that occur in the vascular section of the meniscus are capable of healing. In this case, 
repair surgery can be performed to facilitate healing.  
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2.4.1. Repairable meniscal tears 
In the event of a meniscal tear, the type, location, and length of tear, among other factors, 
including the age of the patient, are used to determine its ability to heal. Tears that occur 
in the vascular region, as well as tears that extend into the avascular region (red and red-
white zone tears), may be repaired in younger patients [73]. In older patients, typically 
only tears located exclusively in the vascular section are repaired (contained within the 
red zone) [12]. The ideal candidate for meniscal repair is a young patient with a tear 
located within 3-4 mm of the meniscal peripheral rim and less than 2 cm in length [73]. 
Currently, only 3-5% of cases are considered for meniscal repair [74]. 
 
Surgical repair can be performed using completely open to all-inside arthroscopic 
procedures. The current gold standard is an all-inside arthroscopic procedure using self-
adjusting suture devices [73].   
 
Good clinical results following meniscal repair are reported for approximately 70-94% of 
cases with 15-24% of cases resulting in subsequent meniscectomy [75]. Studies 
performed by Johnson et al. [76], as well as Rockborn and Messner [67], report 
subsequent meniscectomy rates as high as 24% and 23%. Additionally, the French 
Arthroscopic Society symposium reviewed 203 patients, of which 23% underwent 
secondary meniscectomy at an average follow-up time of 45 months [75]. Repair failure 
can be classified into three categories: early failure due to poor patient selection or 
technical failure (0-6 months); healing failure (6-36 months); and re-tears following 
healing (after 36 months) [75]. Lengthy times required for healing, at least 18 months 
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[77], combined with instability at the repair site may be responsible for healing failure. 
The French Arthroscopic Society symposium also analyzed functional clinical results 
following surgical repair. In 103 cases, 23 patients underwent subsequent meniscectomy, 
18 had residual pain, and 62 had normal functionality [75].  
  
Few studies have compared surgical repair and meniscectomy outcomes. One study by 
Rockburn and Messner [67] analyzed 60 patients at 7 and 13-year follow-up times. After 
seven years, joint space narrowing was significantly less for repaired menisci compared 
to meniscectomized knees. At the 13-year follow-up, however, there was no significant 
difference between the two groups. 
 
Significant ongoing research is investigating improved methods and materials to promote 
healing [78]. This includes: the creation of vascular channels from the periphery rim to 
the inside of the meniscus [79,80], abrasion to the synovium and meniscal surface to 
cause bleeding [81,82], gluing [83,84], fibrin clot injection [85,86], and cell-based and 
gene therapeutics [87,88]. 
 
2.4.2. Non-repairable meniscal tears 
2.4.2.1. Meniscectomy 
Most meniscal tears extend into the inner avascular zone of the meniscus and will either 
heal too slowly or not at all. The treatment of choice in the event of a non-repairable 
meniscal tear is a partial meniscectomy [45,46]. Over 450,000 meniscectomies are 
performed each year in the United States where a section of or the entire meniscus is 
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removed [89]. 
 
Meniscectomies are performed arthroscopically and attempt to preserve as much tissue as 
possible. Arthroscopic knee surgery is minimally invasive and allows for improved 
recovery time and less damage to surrounding tissues compared to open knee surgery.  
 
As discussed previously, the primary function of the meniscus is to redistribute load from 
the femur to the tibia during gait. The menisci are responsible for transmitting in between 
50-85% of the load within the knee [90]. Removal of the meniscus reduces the contact 
area, by approximately 75% [91], along the tibial plateau and consequently results in 
higher stresses. Contact stresses, following meniscectomy, have been noted to increase up 
to 235% [91]. A schematic depicting the changes in load transmission during gait is 
shown in Figure 2.6 [44]. Contact stress magnitude on the tibial plateau is proportional to 
the load during gait and inversely proportional to the contact area. Changes in the contact 
stress distribution after removal of the meniscus have been suggested to lead to 
osteoarthritis proportional in severity to the amount of tissue removed [60]. 
 
Osteoarthritis is a degenerative disease affecting the cartilage and bones in joints 
characterized by articular cartilage loss/damage, osteophyte formation, subchondral bone 
change, and synovitis [69]. Common degenerative changes for arthritic knees are shown 
in Figure 2.7 [92]. Changes are also visible on radiographs: particularly through the 
appearance of osteophytes, joint space narrowing, densification of the subchondral bone, 
and bone cysts. This is commonly referred to as radiographic osteoarthritis. Pain, 
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stiffness, and functional loss combined with radiographic changes are indications for 
symptomatic osteoarthritis [69].  
 
Significant research has been performed evaluating the clinical results following 
meniscectomy [65-72]. A literature analysis performed by Lohmander et al. in 2007 
collected data from 41 independent publications on the prevalence of radiographic 
osteoarthritis following isolated meniscus tears as a function of follow-up time and 
treatment [69]. The results, shown in Figure 2.8, indicate significant degenerative 
changes even after five years. Interestingly, partial versus total meniscectomy did not 
show any significant differences in corresponding osteoarthritis. However, differences in 
procedures, tear types, exact amount of tissue removed, and patient demographics make 
comparing results difficult. Generally, radiographic osteoarthritis was observed in 20-
60% of cases in between 5-10 years and in 20-90% of cases after 10 years follow-up. 
Cases in which meniscus repair was performed were also included and noted high rates of 
osteoarthritis, in between 10-60%. A particular study by Roos et al. was performed to 
analyze the effects 21 years following meniscectomy compared to patients with an intact 
meniscus (control group). The study found mild radiographic changes in 71% of the 
patients and severe radiographic changes in 48% of the patients after meniscectomy, 
compared to control values of 18% and 7% respectively [66]. 
 
Several authors have reported the impact of tear type (degenerative vs. traumatic) on 
functional results [70-72]. Degenerative tears are usually associated with significant 
existing cartilage damage [72] and occur in older patients. An HAS literature analysis 
 17 
[90,93] provided evidence suggesting pre-existing cartilage damage is the primary 
indicator for poor functional results after meniscectomy. For cases with intact cartilage, 
similar percentages observed good clinical results for both degenerative and traumatic 
tears, 49-96% and 58-95% respectively. However, for cases with previously damaged 
cartilage, good clinical results were only observed in 15-65%. 
 
Anterior cruciate ligament (ACL) ruptures very commonly result in secondary meniscal 
tears [94]. As a result, significant research has evaluated the effect of partial or total 
meniscectomy on unstable knees (ACL-deficient). Von Porat et al. published a study 
showing 31% and 59% of cases noted degenerative changes at a 14-year follow-up for 
ACL-deficient knees with an intact meniscus and where the meniscus was partially 
removed respectively [95]. Similarly Nebelung and Wuschech noted an over 50% total 
knee replacement rate at a 35-year follow-up for athletes following meniscectomy in 
combination with a torn ACL [96].  
 
2.4.2.2. Allografts 
Allograft meniscal transplantation is FDA approved based on its ability to relieve pain 
and swelling, and improve mobility [97]. Worldwide allograft transplantation remains 
low, however, due to variable results, availability, cost, and the possibility of transferring 
diseases [46,98]. Indications include: young patients with a stable knee and limited signs 
of osteoarthritis; and ACL-deficient patients with a previously performed meniscectomy 
where the allograft meniscus may improve stability for successful ACL reconstruction 
[99]. Advanced osteoarthritis is considered a contraindication. Abnormal bone and 
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cartilage structure have been observed to have a negative impact on allograft success 
[45,99].  
 
Tissue preservation and storage, sterilization, fixation, and the surgical procedure for 
allograft transplantation vary radically. Allografts are available fresh, frozen with or 
without cryoprotectants, and freeze-dried. Fresh allografts must be used within 12 hours 
[100]; therefore, it is not a practical preservation technique for use in the clinic. Freeze-
dried allografts require additional irradiation for sterilization and results in drastic 
changes to native tissue properties. As such, this technique is also not recommended for 
use [101]. Fresh-frozen allografts are most commonly used. Bone plugs and bone bridges 
may be used to provide additional stability during fixation [102,103]. Otherwise, fixation 
is provided through the use of sutures. Figure 2.9 details the typical fixation methods 
[104,105]. Transplantation is performed either completely open, arthroscopically assisted, 
or all arthroscopically.  
 
The first known allograft transplantation was performed in 1984 [106]. Published results 
evaluating the clinical outcomes after allograft transplantation are limited and difficult to 
compare because of the numerous variables between studies, particularly allograft type, 
fixation, and surgical procedure. A literature analysis performed by Verdonk et al. 
observed a 30-40% chondroprotective (little to no signs of degeneration) effect following 
allograft transplantation; however, the authors suspect a majority of these patients will 
deteriorate over time [99]. Significant research still needs to be performed evaluating the 
effect of allograft transplantation in preventing the onset of osteoarthritis particularly at 
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longer time points. Allografts may also undergo shrinkage over time, among other 
changes, that could affect the ability of the grafts to perform properly [60]. 
 
2.4.2.3. Autografts 
Autografts offer the advantage over allografts of being free from disease transmission, 
have a low infection rate, and are low cost. Several tissues have been used in an attempt 
to replace the meniscus including fat tissue [107], tendons [108,109], and synovial flaps 
[110]. Issues with autograft transplantations include poor mechanical properties, 
difficulty securing the replacement within the joint, and increased morbidity. [46,111] 
Clinical results have shown some promise; however, the disadvantages have discouraged 
continued research.    
 
2.5. Tissue engineering of the meniscus 
Meniscectomy, the gold standard for non-repairable meniscal tears and the most 
commonly performed orthopedic procedure [59], significantly alters the biomechanics of 
the knee joint and can cause osteoarthritis. As such, significant research is ongoing 
evaluating and designing materials that serve as partial or total meniscal replacements 
capable of reestablishing the native functionality of the meniscus and preventing 
degradation of the joint [112].  
 
Both natural and synthetic materials have been proposed as either permanent meniscal 
replacements or tissue conducting scaffolds [46,98,112,113]. Natural materials, 
particularly collagen, provide an innate bioactivity and have shown promise as tissue-
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engineered scaffolds [114-116]. Disadvantages include difficulty tailoring material 
properties and concerns regarding negative immune responses [113]. Synthetic materials, 
on the other hand, are easily tailored over a wide range of properties but possess an 
inherently lower bioactivity compared to natural materials. Fragmentation, synovitis, and 
failure to reduce cartilage damage have also hindered the progress of these materials 
[46,98,113].  
 
2.5.1. Natural biomaterials 
2.5.1.1. Menaflex™ (collagen meniscus implant) 
The partial collagen meniscus implant (CMI) developed by Regen Biologics is a 
biocompatible and resorbable scaffold capable of conducting, or allowing ingrowth of, 
new meniscal tissue [116-118]. The scaffold is composed of chemically cross-linked type 
I collagen derived from bovine Achilles tendon and sterilized via gamma irradiation. 
Glycosaminosglycans commonly found in the meniscus, specifically hyaluronic acid and 
chondroitin sulfate, are also present in the scaffold [118]. The CMI is approved for use in 
Europe. The FDA initially granted approval for the CMI for use in the United States; 
however, approval was revoked in 2010 claiming inadequate data to support use [119].  
 
Indications for clinical use include: an intact meniscal rim and a stable and well-aligned 
knee [120]. Poor mechanical properties and fixation of the scaffold require the presence 
of an intact meniscal rim to provide additional mechanical stability [46,116]. The CMI is 
implanted arthroscopically and trimmed to fit into the surgical site. Fixation of the 
implant to the remaining meniscal tissue is performed with sutures [120]. Figure 2.10 
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shows the CMI implant before and after implantation [120,121].  
 
Rodkey et al. recently published a study comparing the CMI to partial meniscectomy in a 
randomized trial including over 300 patients. The CMI was confirmed to support 
meniscus-like ingrowth and to resorb; however, the authors commented that the tissue 
was not pure fibrocartilage but “hybrid repair tissue.” In patients with the CMI there was 
a statistically significant increase in meniscal tissue after a one-year follow-up. 
Furthermore, fewer complications and reoperations were noted. Further follow-up was 
performed at an average time of five years. No statistically significant differences were 
observed between pain, Lysholm, and patient self-assessment scores between treatment 
groups [116]. An additional study published by Monllau et al. observed new meniscal 
tissue in 68% of cases via MRI at a follow-up period of 4-7 years. The implant, however, 
was smaller than expected and extrusion was commonly observed. Persistent pain was 
documented in 12% of the patients [120,122].  
 
Although the CMI is capable of facilitating the growth of new tissue, it is, as yet, unclear 
if the tissue is adequate to stop the progression of osteoarthritis or even functionally 
similar to meniscal tissue. Significantly more research needs to be performed, especially 
regarding an in-depth analysis of the biomechanical and chemical properties of the new 
meniscal tissue. 
 
2.5.1.2. Other natural biomaterials 
Gelatin [114,123], alginate [124], decellularized meniscal tissues [115,125], and the 
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small intestinal submucosa [126-128] have also been investigated as scaffolds for 
meniscal regeneration.  
 
The small intestinal submucosa is a decellularized extracellular matrix derived from pigs 
and naturally contains various collagens, proteoglycans, and growth factors [126]. 
Previous work by Cook et al. have shown small intestinal submucosa scaffolds initiate 
growth within the meniscus by allowing clot formation and cell conduction [60,129,130]. 
Initial studies show positive results in large posterior medial meniscal tears compared to 
partial meniscectomy. Studies were performed using a dog model with time points at 3, 6, 
and 12 months. Implantation of the small intestinal submucosa resulted in significantly 
less cartilage damage and higher tissue contact area compared to meniscectomy. 
Organized “meniscus-like tissue” was observed and well integrated into the remaining 
native meniscus [126].  
 
Decellularized meniscal tissues have been investigated using rat [125] and porcine [115] 
tissues either with or without additional cell seeding. Similar to the small intestinal 
submucosa, decellularized menisci offer the advantage of providing a natural 
extracellular matrix as a scaffold material. Yamasaki et al. seeded decellularized rat 
meniscus scaffolds with bone marrow derived mesenchymal stem cells (MSC). Tissue 
was regenerated within four weeks in vitro before implantation into rats. Histology 
indicated cartilage damage for scaffolds without cells after four weeks. Scaffolds seeded 
with MSCs showed significantly less cartilage damage; however, no difference was noted 
compared to meniscectomy [125]. It is clear the presence of cells impact the formation of 
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tissue. Longer time points are needed to further evaluate the chondroprotective effect of 
this material.  
 
Gene therapeutic techniques have also been investigated using an injectable calcium 
alginate gel as a delivery vehicle [124]. Bone marrow stromal stem cells transfected with 
the human insulin growth factor-1 (IGF-1) gene were added to alginate solution and 
injected into 48 goats for gelation in situ. Results indicated 92% of the defect was filled 
within 16 weeks compared to 74% without transfection. Minimal tissue growth was 
observed without any treatment. Furthermore, the average histological score of the 
repaired tissue, 28, was similar to normal meniscal tissue, 31. Alginate gel using cells 
without IGF-1 gene transfection, acellular alginate, and no treatment resulted in scores of 
22, 12, and 8 respectively. Although results are very promising, only small defects, 3 mm 
diameter, were evaluated. It is unclear if the size of the defect would have an impact on 
results. Furthermore, the mechanical properties of the repair tissue have to be evaluated.  
 
2.5.2. Synthetic biomaterials: bioactive 
2.5.2.1. Actifit™ 
The Actifit™ partial meniscal implant developed by Orteq Bioengineering is a porous, 
degradable polyurethane-based biomaterial [130-135]. Two segments allow for precise 
control of material properties. Poly(ε-caprolactone) is a biodegradable polyester and 
makes up the “soft segment” of the material providing control over material flexibility 
and degradation rate. A semi-degradable polyurethane derived from 1,4-
butanediisocyante and 1,4-butanediol is the “stiff segment” and provides mechanical 
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strength [133]. The segment ratio was optimized to provide ideal material properties, with 
an approximate ratio of 4:1 soft to hard. Degradation occurs very slowly over 4-6 years 
via hydrolysis [135]. Actifit™ is approved for use in Europe and currently in clinical 
trials in the United States.  
 
Similarly to the collagen meniscus implant, Actifit™ is implanted arthroscopically and 
sutures are used to adhere the implant to the meniscal rim. The implant is typically 
trimmed slightly larger than the defect to allow for slight shrinking in vivo. Indications 
include: non-repairable partial meniscal lesions, intact meniscal rim and horns, a well-
aligned stable knee, and limited cartilage damage [136]. Optical images of the Actifit™ 
implant before implantation are shown in Figure 2.11 [135-136].  
 
The porous structure of the polyurethane-based implant is shown in Figure 2.11(c) [135]. 
Preclinical studies were positive, showing evidence of “fibrocartilage-like” tissue 
ingrowth in dogs after 24 months, Figure 2.11(d) [136]. Initial clinical results are also 
positive, with evidence of “meniscus-like” tissue ingrowth in 85.7% of cases. Post 
operatively, improvements were noted in Lysholm and International Knee Document 
Committee (IKDC) scores after three months [132,135]. Long-term evaluation still needs 
to be performed. Furthermore, similarly to the CMI, it is unclear the new tissue is 
functionally similar to the meniscus. 
 
2.5.2.2. Other bioactive synthetic biomaterials 
Ongoing research is also investigating tissue engineering strategies using polyurethanes 
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[131,132,137] and hyaluronic acid based materials [138-140], as well as materials 
derived from polyglycolic acid, polylactic acid, or combinations thereof [141,142].  
 
The authors of the Actifit™ partial meniscal implant have developed a similar acellular 
implant for total meniscal replacement using the porous polycaprolactone polyurethane 
scaffold. Implants were evaluated for time periods of up to two years in 13 dogs and 
compared to no operation and meniscectomy [132]. Successful integration of the implants 
occurred within the time period evaluated. India ink staining, however, revealed 
significant cartilage degeneration. Mankin scores were used to quantify cartilage damage 
on the tibia and the femur joint surfaces. The average scores for the lateral tibia were 1.3, 
8.4, and 7.6 for no operation, implant at 24 months, and meniscectomy respectively. 
Failure to protect against cartilage damage could be a result of mechanical overloading 
due to inadequate scaffold stiffness. Fragmentation in 6/7 implants was also observed 
after 24 months. This study highlights the importance of scaffold mechanical properties 
in long-term performance.  
 
Chiari et al. recently developed a partial and total meniscus implant based on hyaluronic 
acid and polycaprolactone [139]. Both implants were reinforced with fibers: 
circumferential polylactic acid (PLA) fibers for the total implant and a polyethylene 
terephtalate (PET) net for the partial implant. Implants did not tear and integrated well 
with evidence of tissue ingrowth after six weeks in sheep. However, extrusion was noted 
in certain cases and cartilage damage was significantly increased compared to non-
operated joints. Further studies were performed seeding autologous chondrocytes onto 
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total meniscal implants [140]. Less cartilage damage and more tissue formation was 
observed in the cell-seeded scaffolds after four months in sheep.  
 
Additional research has been performed using polyglycolic acid (PGA) fiber scaffolds 
mechanically reinforced with poly(lactic-co-glycolic acid) (PLGA) [141]. The PGA 
fibers were reinforced by bonding PLGA to the fiber cross points. The compressive 
modulus was observed to increase approximately 28 times after bonding. Allogenic 
meniscal cells were seeded onto fiber scaffolds and cultured for one week in vitro. 
Regenerated meniscal tissue was observed after 10 weeks in rabbits similar in appearance 
to native meniscal tissue. However, biomechanical analysis indicated significantly lower 
modulus in the middle and posterior sections of the regenerated tissue compared to the 
native meniscus. The chondroprotective effects of the implant were not evaluated. 
Further studies need to be performed using a larger, more biomechanically relevant, 
animal model.  
 
2.5.3. Synthetic biomaterials: inert 
2.5.3.1. NuSurface® meniscus implant 
The NuSurface® meniscus implant developed by Active Implants is a non-degradable 
polycarbonate-urethane device for total meniscal replacement [143] and is currently in 
clinical trials. The polycarbonate-urethane implant is a free-floating discoid and does not 
require any fixation. Additional polyethylene fibers are placed circumferentially along 
the periphery of the implant to provide additional mechanical strength.  
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No preclinical or clinical results have been published. MRI images available on the 
developer’s website show the device 24 months after implantation. As shown in Figure 
2.12, implant shows evidence of extrusion and the non-physiological implant shape 
results in increased joint spacing [144]. Contact stress maps developed from in vitro 
experiments and finite element modeling show comparable contact area to the native 
meniscus. Nonetheless, the contact area stress distribution is noticeably different for the 
polycarbonate-urethane implant compared to the intact meniscus [143]. It is difficult to 
come to any conclusions regarding this material for use as a meniscal replacement due to 
the limited information available. The effect of the implant shape on biomechanics and 
long-term functionality and chondroprotection is of concern.  
 
2.5.3.2. Other inert synthetic biomaterials 
A poly(vinyl alcohol) (PVA) hydrogel implant was developed by Kobayashi et al. and 
evaluated in rabbits [145]. The authors observed similar compressive and viscoelastic 
properties of the implant compared to the native rabbit meniscus. The high water content 
and elastic characteristics of hydrogels give them the ability to mimic human tissue more 
than any other class of synthetic biomaterials [146]. After two years in vivo, no wear or 
degradation of mechanical properties was observed. Histology indicated a 
chondroprotective effect compared to meniscectomy [145]. Although the results are 
promising, a rabbit model is not mechanically relevant for translation.  
 
The authors responsible for developing NuSurface® have recently released preclinical 
results documenting a similar device based on polycarbonate-urethane [147]. The implant 
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is reinforced along the periphery meniscal rim with Kevlar® fibers and is similar in shape 
to the native meniscus. Implantation was performed in six sheep using stainless steel 
bolts for fixation. Results indicate mild cartilage damage after implantation for three to 
six months. The implants did not show any signs of wear and remained secured 
throughout the study.  
 
2.6. Additional areas of interest 
Additional types of fibrous tissues of interest for this project include: ligaments, tendons, 
and other types of fibrocartilage. These tissues all exhibit anisotropic tensile properties 
due to highly organized collagen type I fiber orientations. Of particular interest are the 
annulus fibrosus and the anterior cruciate ligament (ACL), as these tissues are also 
among the most commonly injured tissues in orthopedics [59]. Tables 2.1 and 2.2 show 
the biochemical and mechanical properties for these tissues.  
 
2.7. Summary 
Meniscectomy, the gold standard for non-repairable meniscal tears and the most 
commonly performed orthopedic procedure [59], significantly alters the biomechanics of 
the knee joint and can cause osteoarthritis. Meniscal allograft transplantation is FDA-
approved and capable of alleviating pain and swelling; however, worldwide remains low 
due to variable results, availability, donor matching, the possibility of transferring 
diseases, and cost [45,46,98]. As such, there is a clinical need to develop materials 
capable of restoring the native contact pressure distributions during gait within the knee 
and preventing the onset of osteoarthritis.  
 29 
 
Current research focuses on regenerating meniscal tissue using tissue engineering 
[112,118,131,139]. Tissue-engineered degradable scaffolds show promise; although, poor 
mechanical properties limit the use of scaffolds as total meniscal replacements [46]. 
Limited research has been performed on the development of a permanent synthetic 
meniscus. A polymer-based, synthetic meniscus can overcome a majority of current 
issues by allowing the tailoring of mechanical properties, as well as molding of the 
prosthesis to the size and shape of the native cartilage. The selection of biomaterials to 
use for the implant, however, has shown to be a significant issue [46].   
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Figure 2.1: (a) External and (b) internal anatomy of the knee joint [1]. 
 
 
 
 
  
(a) (b) 
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Figure 2.2: Location and anatomy of the medial and lateral meniscus viewed from  
above [8]. 
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Figure 2.3: Schematic of collagen orientations within the meniscus [23]. 
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Figure 2.4: Loading of the meniscus during gait when viewed from the (a) side and (b) 
above [44]. 
 
  
(a) (b) 
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Figure 2.5: Zones of the meniscus, corresponding to the degree of vascularization – red 
zone: vascular, red/white zone: limited vascularization, and white zone: avascular [63]. 
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Figure 2.6: Contact area and stress distribution of the meniscus during loading (a) with 
and (b) without the meniscus present as shown from the front [44]. 
 
  
(a) (b) 
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Figure 2.7: Osteoarthritis is characteristic of cartilage damage and joint enlargement 
(hypertrophy) from the formation of bone cysts and osteophytes [92]. 
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Figure 2.8: Prevalence of radiographic osteoarthritis as a function of follow-up time for 
total or subtotal meniscectomy, partial meniscectomy, and surgical repair. Each point 
represents a data set reported in a published study. Isolated meniscus tears only [69].
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Figure 2.9: Schematic detailing allograft implantation using (a) only sutures [104], (b) a 
bone bridge [105], and (c) bone plugs [105]. 
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Figure 2.10: Schematic showing the collagen meniscus implant (a) before [121] and (b) 
after [120] implantation. The implant is trimmed to fit into the meniscus lesion. (c) 
Scanning electron microscopy image of surface morphology of collagen meniscus 
implant [121]. 
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Figure 2.11: Optical images of the (a) Actifit™ implant [135] detailing the (b) trimming 
procedure [136]. (c) Scanning electron microscopy of the implant’s porous 
microstructure [135]. (d) Micrograph of the Actifit™ implant 24 months after 
implantation into a dog showing staining for fibrocartilage-like tissue [135]. 
 
 
  
 41 
 
 
 
 
Figure 2.12: (a) The NuSurface® polycarbonate-urethane implant [143]. (b) MRI images 
after implantation show slight device extrusion and increased joint space [144]. 
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Table 2.1: Biochemical compositions of various soft tissues. 
 
 
a: [28-31]; b: [4,28,29,32,33]; c: [12,16,17,19,24]; d: [19,34-38]; e: [6,17,39-41] 
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Table 2.2: Mechanical properties of various soft tissues. 
 
a: [53]; b: [54,55]; c: [17,50-52]; d: [19,34]; e: [17,56-58] 
r: radial; c: circumferential 
 
 
 
  
 Tendons
a 
Ligaments
b 
Meniscus
c Annulus 
Fibrosus
d 
Articular 
Cartilage
e 
Tensile Modulus 
(MPa) 
880 
(Achilles) 
99-128 (ACL) 
109-254 
(PCL) 
2-23 (r) 
94-295 (c) 
0.16-410 1-20 
Tensile Strength 
(MPa) 
70-90 
(Achilles) 
22-26 (ACL) 
27-36 (ACL) 
1-4 (r) 
12-19 (c) 
0.2-110 4-9 
Maximum Strain 
(%) 
7-15 
(Achilles) 
27-30 (ACL) 
15-28 (PCL) 
20-60 (r) 
17-34 (c) 
20-30 40-70 
Compressive 
Modulus (MPa) 
  0.22 0.44-0.75 0.53-1.82 
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Chapter 3: Research Goals 
 
The objective of this work was to design a fiber-reinforced polymer for total meniscal 
replacement. Physically cross-linked poly(vinyl alcohol) (PVA) hydrogels were chosen 
as the matrix material. Hydrogels were synthesized using freeze-thaw cycles and 
characterized over a wide range of PVA concentrations and freeze-thaw cycles. 
Characterization techniques included: compression, tension, X-ray diffraction, and 
optical microscopy. A comparison between hydrogels formed via freeze-thaw cycling 
and aging was performed to elucidate the mechanisms during gelation and their relative 
importance. Additionally, the in vitro swelling behavior and impact on material 
properties of PVA hydrogels was analyzed using an osmotic solution characteristic of the 
swelling pressure in the knee and compared with swelling in phosphate-buffered saline 
(PBS) solution. 
 
Hydrogels were reinforced with ultra high molecular weight polyethylene (UHMWPE) 
fibers. The fiber-matrix interface was identified as a weakness due to the poor wettability 
of UHMWPE fibers. Oxygen plasma treatments and a novel chemical grafting technique 
were performed on UHMWPE fibers to increase interfacial adhesion. The chemical 
grafting technique utilized the hydroxyl groups on the fiber surfaces after plasma 
treatment to chemically graft PVA directly onto UHMWPE. PVA-grafted-UHMWPE 
fibers were then physically cross-linked into the hydrogel network. Single fiber pull-out 
tests were used to calculate interfacial shear strength as a quantitative measure of 
interfacial adhesion. Interfacial shear strength was determined as a function of oxygen 
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plasma treatment time, degree of chemical grafting, and fiber spacing. Scanning electron 
microscopy (SEM) was used to determine the mode of failure after fiber pull-out. The 
biocompatibility of PVA-grafted-UHMWPE fiber mats was confirmed using a cell-based 
in vitro cytotoxicity test.   
 
The tensile modulus of UHMWPE-PVA composites was determined as a function of 
fiber volume fraction to determine the ability of the composites to mimic the anisotropic 
tensile modulus distribution of the human meniscus. Finally, UHMWPE-PVA implants 
were manufactured using resin transfer molding in the shape of the native meniscus. 
Evaluation was performed both in vitro, using a knee gait simulator, and in vivo, using a 
sheep model to determine synthesis feasibility and implant biocompatibility. Both of 
these studies were performed in collaboration with the Hospital of Special Surgery, in 
New York City. 
 
The specific aims of this work are:  
1. Design a matrix with similar mechanical and physiological characteristics as that 
of the extracellular matrix of the meniscus. 
2. Improve stress transfer and interfacial shear strength at the fiber-matrix interface. 
3. Evaluate the performance and biocompatibility of fiber-reinforced hydrogels as 
meniscal replacements. 
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Chapter 4: Design a matrix with similar mechanical and physiological 
characteristics as that of the extracellular matrix of the meniscus 
 
4.1. Introduction 
Synthetic biomaterials, as opposed to natural, are easily tailored over a wide range of 
properties [1]. Nonetheless, problems due to fragmentation, synovitis, and failure to 
reduce cartilage damage have limited the use of synthetic biomaterials for meniscal 
applications [2,3]. Restoration of the contact mechanics of the knee joint during gait is 
crucial to prevent the onset of osteoarthritis following meniscal injuries. The proposed 
biomaterial seeks to replicate the anisotropic property distribution of the human meniscus 
using a novel hydrogel-fiber composite material in order to restore native contact 
pressures.  
 
The goal of this aim was to design a hydrogel capable of withstanding the compressive 
forces of the knee without fragmentation, wear, or swelling over time. Two fundamental 
issues were addressed over the course of this work: 1) determination of hydrogel 
properties and the mechanisms responsible for gelation, and 2) evaluation of hydrogel 
swelling behavior and the impact of swelling on hydrogel material properties using 
osmotic pressure solutions.   
 
It is crucial for biomaterials to exhibit controlled swelling behavior in vivo and to 
adequately predict this behavior in vitro. For in vitro experiments, the swelling medium 
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used is a critical decision in accurately determining the material’s swelling behavior [4]. 
Furthermore, different swelling mediums may be best suited to replicate different areas of 
the body due to significant variations in swelling pressure [5,6]. A significant task 
completed in this work was understanding the effects of swelling medium, and 
corresponding pressure, on material swelling behavior and properties. An improved 
understanding of the forces driving swelling behavior provides a framework for 
intelligently designing materials that exhibit controlled responses in vivo. 
 
In this work, physically cross-linked poly(vinyl alcohol) (PVA) hydrogels synthesized 
using freeze-thaw cycles were characterized over a wide range of PVA concentrations 
and number of freeze-thaw cycles. Physically cross-linked PVA hydrogels are extremely 
biocompatible [7], possess similar viscoelastic properties compared to articular [8,9] and 
meniscal cartilage [10], and do not exhibit any wear even after millions of cycles [11]. A 
comparison between hydrogels formed via freeze-thaw cycling and aging was performed 
to elucidate the mechanisms during gelation and their relative importance. Additionally, 
the in vitro swelling behavior and corresponding impact on the material properties of 
PVA hydrogels was analyzed using an osmotic solution characteristic of the swelling 
pressure in the knee and compared with swelling in phosphate-buffered saline (PBS) 
solution. 
 
4.2. Background 
4.2.1. Hydrogels 
Hydrogels are three-dimensional hydrophilic polymer networks characteristic of very 
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high swelling ratios in water [12]. Hydrogels remain insoluble in water due to the 
presence of physical, chemical, or ionic cross-links [13]. Physical cross-links can include 
crystallites, polymer chain entanglements, and hydrogen bonds [14]. Hydrogels can be 
tailored over a wide range of material properties through modification of polymer type 
and composition, cross-linking density, and manufacturing methods. Commonly tailored 
properties include: charge, modulus, porosity, network morphology, degradability, and 
bioactivity [13,15,16]. The high water content and elastic characteristics of hydrogels 
give them the ability to mimic human tissue more than any other class of synthetic 
biomaterials [12]. As a result, hydrogels have been considered for a wide range of 
applications, particularly drug delivery [17-19] and tissue engineering [15,16,20]. 
Hydrogels can be synthesized using either natural materials, such as agar [21,22], 
hyaluronic acid [23.24], and collagen [25,26], or synthetic polymers, such as 
poly(ethylene glycol) [27,28], poly(vinyl alcohol) [29,30], and poly(lactic-co-glycolic 
acid) [31,32].  
 
4.2.2. Poly(vinyl alcohol) hydrogels 
PVA is available commercially as a powder; however, the monomer vinyl alcohol is not 
stable under normal conditions. As a result, PVA is synthesized by hydrolysis of 
poly(vinyl acetate) [7]. The degree of hydrolysis, or extent of conversion of poly(vinyl 
acetate) to PVA, of the final product impacts the resultant properties, including solubility 
and crystallizibility [33].  
 
PVA hydrogels are formed through either chemical or physical cross-linking. Chemical 
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cross-linking techniques include using cross-linking agents [34,35], electron beam 
irradiation [36,37], and γ-irradiation [38,39]. Common cross-linking agents are aldehyde-
based, such as glutaraldehyde, formaldehyde, and acetaldehyde, and form an acetal 
bridge between the hydroxyl groups in PVA under acidic conditions [7,40]. Residual 
cross-linker can be cytotoxic even at small concentrations, especially for glutaraldehyde 
[41]. Therefore, chemical cross-linking using cross-linking agents is not a popular 
technique for biomedical applications. Chemical cross-linking via irradiation is preferred, 
as it does not require the use of any toxic chemicals to aid in cross-linking [7]. Degree of 
cross-linking can be tailored by irradiation dose [37,42].   
 
Physical cross-linking of PVA is also possible through heat treatments, such as annealing 
and dehydration [43,44]; phase separation using theta-solutions, such as poly(ethylene 
glycol) [45]; and freeze-thaw cycling [29,46-48]. All of these methods result in 
crystallization of PVA, where the degree of crystallization can be tailored through 
alteration of the processing methods. Similarly to chemical cross-linking using irradiation, 
physical cross-linking methods do not require the use of any toxic agents and are 
extremely biocompatible. PVA hydrogels formed through physical cross-linking also 
exhibit improved mechanical properties compared to chemically cross-linked gels [7].  
 
In particular, the viscoelastic behavior of physically cross-linked PVA hydrogels via 
freeze-thaw cycling has been shown to be comparable with that of articular and meniscal 
cartilage, making them exceptionally attractive biomaterials for tissue engineering 
applications [8-10]. Freeze-thawed PVA hydrogels are formed through phase separation 
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that occurs during freezing. During exposure to cold temperatures water freezes, 
expelling PVA and forming regions of high PVA concentration. As the PVA chains come 
into close contact with each other, crystallite formation and hydrogen bonding occur. 
These interactions remain intact following thawing and create a non-degradable three-
dimensional hydrogel network [29,46-48]. The proposed structural model for PVA 
hydrogels formed by freezing and thawing is depicted in Figure 4.1 [49].  
 
Peppas first reported freeze-thawed PVA hydrogels in 1975 [50]. Since then, significant 
research has been performed analyzing the impact various processing parameters and 
PVA properties have on hydrogel properties and gelation [7]. This includes: freezing and 
thawing time [50,51], rate of freezing and thawing [52,53], freezing and thawing 
temperature [54], number of cycles [46,47], polymer concentration [50,51], PVA 
hydrolysis [55], PVA molecular weight [56,57], and solvent [58,59]. Increasing freezing 
and thawing time, as well as polymer concentration, increases the degree of 
crystallization [50,51]. Stauffer and Peppas showed optimal results for hydrogels that 
were frozen for 24 hours compared to gels prepared with less freezing time [51]. 
Furthermore, by increasing the number of freeze-thaw cycles, the degree of polymer 
phase separation [46], crystallite formation [47], and hydrogen bonding [48] can be 
augmented. Watase et al. studied PVA hydrogels synthesized using varying grades of 
PVA (96.0-99.9% hydrolysis), finding the large acetate groups inhibited gelation [55]. 
Several researchers have also investigated the addition of various solvents during 
synthesis, including: ethylene glycol [59], dimethyl sulfoxide [58,60], and glycerine [59]. 
Organic solvents with low freezing temperatures, in particular, allow for crystallization to 
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occur without phase separation. This produces transparent hydrogels even after the 
solvent is exchanged with water [58]. These studies show that through careful 
modification of the processing parameters during freeze-thaw cycling, the degree of 
crystallinity, or physical cross-linking, can be controlled allowing for tailoring of the 
hydrogel’s mechanical properties.  
 
Several researchers have documented aging, or additional crystallization, of freeze-
thawed hydrogels both in solution [61] and in sealed containers not in solution [47,62-64]. 
Swelling medium and temperature were observed to have an effect on PVA aging rate 
[61]. Increases in crystallization were witnessed for periods of up to 500 days in sealed 
containers [63] and up to 120 days in solution [61]. This is important to consider in 
evaluating material properties over time. Aging has also been observed to occur to PVA 
solution, without any initial cross-links [50,65-66].  
 
The biocompatibility, processing ease, high swelling ratio, and mechanical strength of 
freeze-thawed PVA hydrogels have encouraged extensive research developing this 
material for tissue engineering applications, particularly articular cartilage [4,67-70] and 
nucleus pulposus [11,30,71], as well as, drug delivery applications [57,72]. PVA 
hydrogels can also be easily modified to impart additional functionalities, including 
bioactivity [7,73,74]. Load bearing applications require exceptional wear properties. For 
example, the knee experiences approximately two million cycles a year equating to over 
four thousand cycles every day [75]. A study performed by Katta et al. (2007) showed no 
wear on the articulating surface of PVA hydrogels after 100,000 cycles [67]. No change 
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was observed in polymer content or hydrogel modulus even after ten million cycles using 
a human cadaver intervertebral disc compression model [11]. SaluCartilage™, a PVA 
hydrogel for the repair of cartilage defects, underwent clinical trials in Europe. Results 
indicated poor fixation and integration of the polymer with the surrounding tissue, as well 
as significant deswelling, where the implants were surrounded by fluid at the end of the 
study [76]. This emphasizes the importance of characterizing and controlling implant 
swelling behavior.  
 
Promising results have been reported regarding a two year in vivo study of PVA 
hydrogels as total meniscal replacements in rabbits. The authors observed similar 
compressive and viscoelastic properties of the implant compared to the native rabbit 
meniscus. After two years in vivo, no wear or degradation of mechanical properties was 
observed. Histology indicated a chondroprotective effect compared to meniscectomy [10]. 
Although the results are promising, a rabbit model is not mechanically relevant for 
translation.  
 
Freeze-thawed PVA hydrogels are limited in that they cannot be formed in situ and their 
hydrophilicity inhibits cell attachment and protein adsorption without any chemical 
modification or additives [77,78]. The proposed application within this report, however, 
does not require integration with surrounding tissue or in situ gelation.  
 
Dissolution of the crystalline regions in freeze-thawed PVA has been reported [7,79], 
leading to concerns regarding long-term stability. Thomas et al. (2003) showed the 
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addition of poly(vinyl pyrrolidone) (PVP) improved hydrogel stability through interchain 
hydrogen bonding between the hydroxyl groups on PVA and the carbonyl groups on PVP. 
A schematic of the interchain bonding between PVA and PVP is shown in Figure 4.2 [56]. 
Stability was quantified using polymer weight loss after 120 days at various PVA to PVP 
weight ratios. Results indicated minimal dissolution for hydrogels synthesized using 99 
wt% PVA and 1 wt% PVP, approximately 2.8%. Higher concentrations of PVP sterically 
inhibited crystallite formation [56].  
 
4.2.3. Macromolecular-based solutions as swelling media 
For soft tissue applications, it is important to adequately model the in vivo response of the 
proposed material using in vitro model systems to ensure that the material retains its 
initial size and shape. Additionally, in the case of hydrogel composite materials, 
controlling the swelling behavior is also essential in preserving the substrate-matrix 
interface. The proposed composite is a fiber-reinforced PVA hydrogel for meniscal 
replacement, where the reinforcing fibers are ultra-high molecular weight polyethylene 
(UHMWPE). In this case hydrogels have the ability to swell or deswell drastically, 
however, hydrophobic fibers do not change volume in aqueous medium or in vivo. 
Incongruent volumetric changes between the hydrogel and fibers can form residual forces 
at the fiber-matrix interface, leading to interfacial debonding and corresponding 
composite failure. 
 
The presence of external forces and a high osmotic pressure due to the presence of 
charged proteoglycans is known to influence the hydration of tissues present within load-
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bearing joints [80]. The swelling pressure of tissues within the hip and knee are between 
0.3 and 2.5 atm, and reach as high as 3.5 atm for the intervertebral disk [5,6]. Currently, 
most in vitro studies utilize phosphate-buffered saline (PBS) solution as a swelling 
medium. PBS, however, does not replicate the swelling pressure of load-bearing joints. 
The small size of the molecules within PBS leads to rapid equilibration with the 
biomaterial. Hydrogel mechanical properties and their ability to function as tissue-
engineered scaffolds are strongly influenced by the swelling properties [81], as such it is 
important that an in vitro model adequately considers the swelling pressure of the 
surrounding tissues that the biomaterial will experience in vivo.  
 
Macromolecule-based solutions can create a permanent osmotic pressure gradient more 
characteristic of the environment in vivo for load-bearing joints. Significant research has 
been performed using macromolecule-based solutions to study the swelling behavior of 
cartilage [5,82]; however, very little research has applied this technique to biomaterials. 
Spiller et al. [4] compared the swelling behavior of PVA hydrogels ex vivo in full 
thickness cartilage defects with the in vitro behavior in PBS (osmotic pressure of 0 atm) 
and in an osmotic solution with a pressure of 0.95 atm, a value within the range of the 
swelling pressure of articular cartilage in the knee. The swelling behavior of the 
hydrogels was the same in cartilage ex vivo and in osmotic solution, and was significantly 
different from that in PBS. It is important to note that the lack of fluid flow or mechanical 
loading during this study made it an imperfect portrayal of in vivo behavior. Nonetheless, 
the benefit of osmotic solutions as model systems was clearly displayed. The study, 
however, only characterized the behavior of hydrogels prepared with 10 wt% PVA 
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prepared using six freeze-thaw cycles [4]. 
 
4.3. Materials and methods 
4.3.1. PVA hydrogel synthesis 
PVA (>99% hydrolyzed), with a molecular weight of 89,000-98,000 g/mol, and PVP, 
with a molecular weight of 40,000 g/mol, were obtained from Sigma Aldrich (St Louis, 
MO). PVP was added in small amounts to the hydrogel formulation to improve network 
stability through interchain hydrogen bonding, as mentioned previously [56]. Polymer 
solutions were prepared by mixing 10, 20, 30, or 35 wt% polymer, composed of 99 wt% 
PVA and 1 wt% PVP, in deionized water. The container was sealed and autoclaved at 
121°C for two to four hours to ensure complete dissolution of PVA. Polymer solutions 
were poured into 24-well polystyrene tissue culture trays for cylindrical samples or 
between two glass plates with a Teflon spacer for rectangular samples. Freeze-thawed 
samples were subjected to 21 hours of freezing at -20°C and three hours of thawing at 
room temperature for up to ten cycles. Aged samples, without any freeze-thaw cycles, sat 
at room temperature for periods of up to 31 days in closed containers wrapped with 
parafilm. No significant dehydration was observed during aging. PVA solutions with 10 
and 20 wt% polymer did not undergo gelation due to aging over the period studied.  
 
4.3.2. Mechanical properties 
A bench-top mechanical testing machine, an Instron Materials Testing System Series 
4442 (Norwood, MA) with a 50 N load cell, was used to test cylindrical specimens in 
unconfined compression. Tests were performed in PBS obtained from Sigma Aldrich (St 
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Louis, MO) at 37°C. Each sample was compressed to 15% strain at a strain rate of 100% 
per minute. The sample size was approximately 15 mm in diameter and 7 mm in height.  
 
Rectangular specimens were tested in tension. Tests were performed in air at room 
temperature after determining that the experimental media and temperature did not have 
an effect on the results over the specified time periods. Each sample was subjected to a 
strain rate of 10% per minute to 15% strain. The sample size was approximately 5 mm in 
width and 1.5 mm in thickness with a gauge length of approximately 20 mm. Strain rates 
for tensile and compressive testing were chosen in order to adhere to previously 
developed protocols, however, compressive and tensile testing was performed at various 
strain rates between 10% and 100% strain per minute and no dependence of either 
compressive or tensile modulus on strain rate was found in this range.  
 
Both compressive and tensile moduli were calculated from the average slope of the initial 
linear portion (1–5% strain) of the stress versus strain curve for 10, 20, 30, and 35 wt% 
PVA hydrogels synthesized from one to ten freeze-thaw cycles. Compressive modulus 
was calculated for aged 30 and 35 wt% PVA hydrogels at various aging times up to 31 
days. At least five independent samples were tested for each set of hydrogels (n = 5). 
 
4.3.3. Crystallinity 
4.3.3.1. Bound water determination using differential scanning calorimetry 
One method to evaluate the degree of crystallinity within PVA hydrogels is through 
measurement of the amount of water bound to the PVA chains. Water is capable of 
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hydrogen bonding to hydroxyl groups on PVA chains [44,83]. A schematic of the two 
different states of water in PVA hydrogels is shown in Figure 4.3. Bound water does not 
freeze or thaw at the same temperature as unbound water. As hydrogen bonds are formed 
between the PVA chains, fewer bonding sites are available for water. Differential 
scanning calorimetry (DSC) can be used to measure the amount of bound water by 
analyzing the heat absorbed during melting of unbound water crystals, ΔHs, as shown in 
equation 4.1: 
 
 (4.1) 
 
The heat of fusion enthalpy of bulk water, ΔHw, was found to be 331 J/g, as determined 
by measuring the melting endotherm of a pure water sample, compared to literature 
reports of 333.5 J/g [84]. The amount of bound water was measured for hydrogels 
between zero and six freeze-thaw cycles for both 10 and 20 wt% PVA hydrogels (n = 4). 
Approximate sample size was 10 mg. Experiments were performed on a TA Instruments 
Q2000 DSC (New Castle, DE) with a ramp speed of 10°C/min. 
 
4.3.3.2. Wide angle X-ray diffraction 
Wide-angle X-ray diffraction (WAXD) can be used to directly determine the crystalline 
nature of materials. Crystalline materials diffract X-rays providing information regarding 
interplanar spacings [85]. WAXD profiles were collected using a Rigaku SmartLab® X-
Ray Diffractometer (The Woodlands, TX) with an operating tube voltage and current of 
40 kV and 30 mA respectively. Spectra were collected at room temperature using a 0.04° 
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2θ/s scan rate with a four second dwell time in the 2θ range 15°-35°. The 2θ range was 
chosen based on previous work performed by Ricciardi et al. indicating the primary 
crystalline peak for PVA occurs at 19.4° 2θ [47,86]. This corresponds to a d spacing of 
4.68 Å and crystalline dimensions in the [   ̅] lattice direction [47,86]. The scan rate and 
dwell time were chosen to minimize the time required for testing and to prevent drying of 
the sample while maintaining spectra resolution. Mass measurements of the samples 
before and after testing indicated minimal water loss (< 2 wt%). WAXD was performed 
on 10, 20, 30, and 35 wt% PVA freeze-thawed samples between one and six freeze-thaw 
cycles, as well as, on 30 and 35 wt% PVA aged hydrogels at various aging times up to 31 
days (n=3). 
 
WAXD profiles were smoothed using Savitzky-Golay’s smoothing filter. Crystallinity 
was calculated using equation 4.2: 
 
 (4.2) 
 
where PVA crystalline peak area is the area at 19.4° 2θ and total area is the entire area 
within the 2θ range of 15°-35°. The obtained crystallinity represents a relative value and 
can be compared to other samples provided the same testing method is used; however, it 
does not represent an exact measurement of the crystallinity percentage as the equation is 
not normalized using known crystallinity values.  
 
 
  
Relative Crystallinity (%) =
PVA crystalline peak area
total area
´100%
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4.3.4. Microstructure 
In imaging a hydrogel’s microstructure it is imperative to remain in the hydrated state for 
an accurate image. More common imaging techniques, such as scanning electron 
microscopy and transmission electron microscopy, result in changes in crystallinity and 
hydrogel microstructure due to dehydration during imaging. In our experience, even 
environmental scanning electron microscopy results in some extent of drying. In order to 
image hydrogels in the hydrated state, samples were sectioned from cylindrical, hydrated 
hydrogel specimens to 20 μm in thickness using a Vibratome UltraPro 5000 cryostat 
(Bannockburn, IL) in the direction perpendicular to the cylindrical axis. Optical 
micrographs taken immediately following sectioning, using a magnification of 20x, were 
used to analyze hydrogel microstructure and pores. Samples imaged included both freeze-
thawed hydrogels, between one and eight freeze-thaw cycles with 10, 20, 30, and 35 wt% 
PVA, and aged hydrogels, various aging times of up to 31 days for 30 and 35 wt% PVA, 
(n=4). ImageJ image processing software, using threshold, was employed to approximate 
the average porosity of the PVA hydrogels as a function of processing parameters. 
 
4.3.5. In vitro swelling behavior 
In this work, poly(ethylene glycol) (PEG), 20,000 g/mol, obtained from Crescent 
Chemical Co. (Islandia, NY), was dissolved in PBS to create osmotic solutions 
mimicking the swelling pressure of articular cartilage in the knee. Equation 4.3 was used 
to calculate the PEG concentration, c2, required for an osmotic pressure, Π, of 0.95 atm, a 
value in the middle of the swelling pressure range reported in the literature for articular 
cartilage in the knee: 
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 (4.3) 
 
where M2 is polymer molecular weight, R is the universal gas constant, and T is absolute 
temperature [4,5]. The second and third virial coefficients, B and C, for 20,000 g/mol 
PEG are 2.59 x 10
-3
 and 13.5 x 10
-3
, respectively [5]. For 1 l of PBS, 92.3 g of PEG was 
dissolved for an osmotic pressure of 0.95 atm. Cylindrical hydrogel samples were placed 
in dialysis tubing and dialysis clips were used to clip both ends of the tube. All samples 
were approximately the same size in volume, 1 cm
3
, to reduce the effects of sample size 
or geometry on the results. Dialysis tubing with a molecular weight cut-off of 3,500 
g/mol (Fisher Scientific, Pittsburgh, PA) was used to prevent any uptake of PEG by the 
hydrogels and maintain solution pressure. The hydrogel and tube assembly was placed in 
either PEG solution (0.95 atm) or in PBS (0 atm) for periods of up to 28 days. Samples 
were kept at 37°C for the length of the study. Additionally, the volume of the swelling 
medium was 100x larger than the volume of the immersed samples to prevent significant 
changes in the pressure of the swelling medium due to water flux into or out of the 
hydrogels over the length of the study. Initial hydrogel mass was recorded and compared 
with hydrogel mass at various time points for up to 4 weeks. The swelling ratio, shown in 
equation 4.4, was calculated as the ratio of the mass of the hydrogel at each time point, 
swollen mass, to the initial mass. Using this method, samples with a swelling ratio close 
to one exhibit minimal volume changes. Equilibrium water content, defined in equation 
4.5, was also calculated using hydrogel swollen mass and dry mass. Hydrogels were dried 
at room temperature in a vacuum oven for one week to obtain dry mass.  
  
P = RT
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M2
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÷ 
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This study was performed for hydrogels with 10, 20, 30, and 35 wt% PVA after 2, 4, and 
6 freeze-thaw cycles (n = 4). Further analysis was performed on hydrogels after swelling 
in vitro using the techniques described previously, including: WAXD, mechanical testing, 
and optical microscopy. Additional testing following swelling was performed after 
hydrogels reached equilibrium to reduce the effects of the different geometries required 
for testing on final results.  
 
 (4.4) 
 
Equilibrium Water Content   1 - 
dry mass
swollen mass
   100%  (4.5) 
 
4.3.6. Statistical analysis 
All values are reported as means ± standard deviation for at least three independent 
samples. Statistical analysis was performed using a one-way analysis of variance 
(ANOVA) followed by a Bonferroni post hoc test with a 95% confidence interval (p < 
0.05) to compare mean values. 
 
4.4. Results 
4.4.1. Hydrogel mechanical properties 
4.4.1.1. Freeze-thawed PVA hydrogels 
Freeze-thawed hydrogels, as shown in Figure 4.4, appeared opaque regardless of polymer 
concentration or number of freeze-thaw cycles. Figures 4.5 and 4.6 show typical stress vs. 
  
Swelling Ratio =
swollen mass
inital mass
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strain curves during compressive and tensile testing of PVA hydrogels. In compression, 
PVA hydrogels exhibited a hyperelastic response over the strain range tested. Hydrogels 
in tension, however, exhibited a linear elastic stress vs. strain curve.  
 
The compressive modulus of PVA as a function of freeze-thaw cycles and polymer 
concentration is shown in Figure 4.7. For all polymer concentrations linear relationships 
between freeze-thaw cycles and modulus were observed through the first six freeze-thaw 
cycles. After six cycles, the compressive modulus did not increase significantly (p > 0.05) 
and reached the plateau values described in Table 4.1. Trend lines are shown in Figure 
4.7 representing the best fit through the first six freeze-thaw cycles for each polymer 
concentration (R
2
 = 0.96 for 35 wt% PVA, R
2
 = 0.95 for 30 wt% PVA, R
2
 = 0.97 for 20 
wt% PVA, R
2
 = 0.93 for 10 wt% PVA) and the average modulus within the plateau 
region. In the case of 30 and 35 wt% PVA, better linear fits were obtained when the 
plateau started after the fifth cycle, however, for consistency when comparing with other 
data the plateau was not started until the sixth. 
 
Polymer concentration also had a significant effect on the compression modulus, with 
increasing values at higher concentrations (p < 0.05). The compressive modulus was 
shown to vary between 0.0012 ± 0.0005 and 0.85 ± 0.04 MPa depending on the polymer 
concentration and number of cycles tested. These values are similar to the values reported 
for aggregate compressive modulus determined using the biphasic theory of various 
cartilage tissues, including the native meniscus (0.22MPa) [87], the temporomandibular 
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joint (TMJ) disk (16–29 kPa) [88], articular cartilage (0.53–1.82 MPa) [89], and others 
(Table 2.2).  
 
Tensile modulus values, plotted in Figure 4.8, also increased with polymer concentration 
and through the first six freeze-thaw cycles (p < 0.05). Trend lines are again shown 
representing the best fit through the first six freeze-thaw cycles (R
2
 = 0.98 for 35 wt% 
PVA, R
2
 = 0.95 for 30 wt% PVA, R
2
 = 0.96 for 20 wt% PVA, R
2
 = 0.99 for 10 wt% 
PVA) and the average modulus within the plateau region. The tensile properties of PVA 
hydrogels were much lower than the range reported in literature for the human meniscus 
(2–295 MPa) [90], the TMJ disk (18–101 MPa) [90], articular cartilage (1–20 MPa) [91], 
and others (Table 2.2), which was expected. Like the trends observed in compression, no 
statistically significant changes were noted between six and ten cycles for all polymer 
concentrations, with the exception of slight statistical differences noted when comparing 
eight and ten cycles for 20 wt% PVA and when comparing six and ten cycles for 30 wt% 
PVA (in this case, statistically significant changes were noted between six and eight 
cycles, as well as between eight and ten cycles) (p < 0.05). The average plateau tensile 
modulus for each polymer concentration following six cycles is described in Table 4.1.  
 
4.4.1.2. Aged PVA hydrogels 
Aged hydrogels, as shown in Figure 4.9, appeared translucent regardless of polymer 
concentration or duration of aging. Stress vs. strain curves for aged PVA hydrogels 
showed a hyperelastic response in compression similarly to freeze-thawed PVA 
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hydrogels shown in Figure 4.5. Compression tests were performed for hydrogels with 30 
and 35 wt% PVA after aging for 3, 17, 24, and 31 days.  
 
The compressive modulus for PVA hydrogels as a function of aging time and polymer 
concentration is shown in Figure 4.10. Time required for gelation was strongly dependent 
on polymer concentration, where 10 and 20 wt% PVA did not fully gel in the time frame 
studied, and 30 and 35 wt% PVA gelled within three days. At the end of 31 days, 10 wt% 
PVA solution was still a liquid; however, 20 wt% PVA was too viscous for flow. 
Nonetheless, 20 wt% PVA remained too soft for testing. This indicates gelation rate was 
faster for samples with higher PVA concentrations. This is likely a result of a smaller 
distance between PVA chains at higher concentrations facilitating crystallization in lieu 
of freezing and thawing. Additionally, as aging duration increased, compressive modulus 
increased (p < 0.05). Hydrogels with 30 and 35 wt% PVA reached compressive modulus 
values of 0.34 ± 0.10 and 0.41 ± 0.07 MPa respectively after aging for 31 days. Of note, 
the compressive modulus for aged hydrogels was lower compared to freeze-thawed 
hydrogels of similar polymer concentrations after six freeze-thaw cycles (p < 0.05). 
 
4.4.2. Crystallinity 
4.4.2.1. Bound water 
Bound water, water that is hydrogen bonded to PVA, does not freeze or thaw at the same 
temperature as unbound water. Significant research has been reported on the 
characterization of bound water within PVA hydrogel networks. However, most of the 
reported work is for non-cross-linked PVA solutions [92], chemically cross-linked 
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systems [44,93,94], non-freeze-thawed physically cross-linked systems [44,83,84,95], or 
systems with a constant number of freeze-thaw cycles [44,96]. Limited research has 
investigated the effect of freeze-thaw cycling on bound water. The amount of bound 
water was determined as a function of freeze-thaw cycles and polymer concentration by 
melting the frozen, unbound, water crystals in the hydrogel as described in the 
experimental section. A typical ice-melt curve is shown in Figure 4.11. Figure 4.12 is a 
plot of bound water measured as moles of water per mole of –OH in PVA hydrogels with 
freeze-thaw cycling. Bound water shows a slight decrease with cycling indicating that 
hydrogen bonding is occurring between the PVA chains, reducing the ability of the water 
to bind to the hydroxyl groups on PVA. Notwithstanding the large relative standard 
deviations, decreases in bound water are noted through the first two cycles. The early 
decreases, however, do not correspond to the trends observed in modulus (Figure 4.7 and 
4.8). In fact, modulus continues to increase after two cycles. 
 
4.4.2.2. Wide-angle X-ray diffraction 
4.4.2.2.1. Freeze-thawed PVA hydrogels 
Using WAXD, the PVA crystalline peak was found to occur at 19.55° ± 0.13° 2θ, which 
is in good agreement with previous work documenting the peak at 19.4° 2θ [47,86]. 
Typical WAXD spectra for freeze-thawed PVA hydrogels are shown in Figure 4.13. 
Relative crystallinity was calculated according to equation 4.2 as a function of both PVA 
concentration and freeze-thaw cycles. As shown in Figure 4.14, crystallinity increased 
linearly for all PVA concentrations through the first three freeze-thaw cycles. After three 
cycles, crystallinity did not increase significantly (p > 0.05) and reached a plateau value. 
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Trend lines were added to Figure 4.14 representing the best fit through the first three 
freeze-thaw cycles for each polymer concentration (R
2
 = 0.998 for 35 wt% PVA, R
2
 = 
0.99 for 30 wt% PVA, R
2
 = 0.92 for 20 wt% PVA, R
2
 = 0.98 for 10 wt% PVA) and the 
average crystallinity within the plateau region. The average plateau crystallinity for each 
polymer concentration following three cycles is described in Table 4.1. The trends in 
crystallinity correspond to the same early decreases observed in bound water; however, 
as stated previously, modulus continues to statistically increase with increasing cycles (p 
< 0.05). 
 
Similar to the trends observed in mechanical properties, polymer concentration also had a 
significant effect on crystallinity, with increasing values at higher concentrations (p < 
0.05). In general, crystallinity was shown to vary between 0.03 ± 0.02 and 5.32 ± 0.93% 
depending on polymer concentration and number of cycles tested. 
 
4.4.2.2.2. Aged PVA hydrogels 
WAXD spectra for aged PVA hydrogels was similar in appearance to freeze-thawed 
hydrogels and no differences were observed in the location of the PVA crystalline peak. 
Relative crystallinity was calculated as a function of both PVA concentration and aging 
duration. As shown in Figure 4.15, crystallinity was dependent on both aging time and 
polymer concentration. In the case of 30 and 35 wt% PVA, crystallinity plateaued after 
17 and 10 days respectively (p < 0.05). In general, trends in crystallinity correspond well 
to the trends observed in modulus with aging time. 
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Similar to the trends observed in mechanical properties, polymer concentration also had 
an effect on crystallinity, with increasing crystallinity at higher concentrations for low 
aging times (p < 0.05). Overall, crystallinity was shown to vary between 0.42 ± 0.08 and 
3.13 ± 0.98% depending on the polymer concentration and duration of aging tested. 
 
4.4.3. Microstructure 
4.4.3.1. Freeze-thawed PVA hydrogels 
In imaging a hydrogel’s microstructure, it is imperative that the hydrogel remain in the 
hydrated state to ensure an accurate representation of the hydrated structure. More 
common imaging techniques, such as scanning electron microscopy and transmission 
electron microscopy, result in changes in crystallinity and hydrogel microstructure due to 
drying during imaging. It was the author’s experience that even environmental scanning 
electron microscopy resulted in some extent of drying. To prevent the effects of drying, 
PVA hydrogel morphology was analyzed using optical micrographs obtained from 
hydrated hydrogel sections. Investigation of freeze-thawed PVA hydrogel microstructure 
shows increasing pore size and corresponding thickening of PVA-rich regions with 
increasing freeze-thaw cycles and polymer concentration. Representative micrographs of 
PVA cross-sections as a function of freeze-thaw cycles and PVA concentration are shown 
in Figure 4.16. Microstructural remodeling of the PVA phase occurs as water freezes, 
expelling PVA and creating regions of concentrated polymer. This process repeats with 
each cycle, creating regions with increasing concentrations of PVA. Additionally, with 
each cycle the water freezes and expands, pushing the PVA chains into close contact. 
This mechanism is also believed to decrease the distance between the PVA chains, 
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facilitating hydrogen bonding and crystallite formation. The macroscopic remodeling of 
the polymer-rich phase shows a progressive increase in polymer-rich zones through the 
first eight cycles, where even after four and six cycles differences in microstructure can 
be observed. Both gel porosity and pore size appear to increase with freeze-thaw cycles, 
with pore sizes above 20 μm after eight cycles. The morphology also shows increasing 
phase separation, in which the difference between water- and polymer-rich regions 
becomes clearer with increasing freeze-thaw cycles and polymer concentration.  
 
A quantitative analysis of the porosity of PVA hydrogels with freeze-thaw cycles is 
shown in Figure 4.17. A progressive increase in porosity is noted through at least four 
cycles with significant differences noted up until five or six cycles in certain cases (p < 
0.05). The average porosity increases from 1.4 ± 0.7 % after one freeze-thaw cycle to 
46.4 ± 2.8% after six cycles depending on polymer concentration. Average porosity after 
six freeze-thaw cycles for each polymer concentration is shown in Table 4.1. It is 
important to note that the overall volume fraction of polymer and water does not change 
with freeze-thaw cycling. Observed changes in porosity are a result of hydrogel phase 
separation and the densification of the water and polymer-rich regions. 
 
4.4.3.2. Aged PVA Hydrogels 
Evaluation of aged PVA hydrogels does not show any microstructural changes or phase 
separation with increased aging or polymer concentration. This is expected, as the 
mechanism in which phase separation occurs for freeze-thawed hydrogels, namely water 
freezing, is not present during aging. The representative micrographs of PVA cross-
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sections as a function of aging time and PVA concentration are shown in Figure 4.18. 
Quantitative analysis of hydrogel porosity did not show any discernible dependence on 
aging time (p > 0.05) with average values presented in Table 4.1. The appearance of lines 
within the hydrogel structure is an artifact that occurs during hydrogel sectioning.  
 
4.4.4. In vitro swelling behavior 
4.4.4.1. Swelling ratio 
The swelling behavior and equilibrium water content of freeze-thawed hydrogels as a 
function of polymer concentration and freeze-thaw cycles was characterized in both non-
osmotic (PBS, 0 atm) and osmotic solutions (PEG-based, 0.95 atm), as shown in Figures 
4.19 to 4.24. As stated previously, swelling ratio was defined as the ratio between 
swollen and initial hydrogel mass and equilibrium water content was defined as shown in 
equation 4.5. No significant changes in swelling ratio were observed with respect to time 
after two weeks for any hydrogel formulation tested in either non-osmotic, Figure 4.19, 
or osmotic, Figure 4.20, solution (p > 0.05). Additionally, swelling in osmotic medium 
resulted in significantly lower values of equilibrium water content compared with 
swelling in non-osmotic solution, as indicated when comparing Figure 4.21 (non-
osmotic) and 4.22 (osmotic) (p < 0.05). Furthermore, in either in vitro testing medium, 
PVA hydrogel swelling ratio and equilibrium water content were affected primarily by 
initial polymer concentration. Hydrogels with a low concentration of PVA initially 
deswelled, while those with a high concentration swelled. For hydrogels swollen in PBS, 
hydrogels prepared with 20 wt% PVA reached a swelling ratio just under one, whereas 
hydrogels prepared with higher concentrations swelled and those with lower 
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concentrations deswelled significantly. On the other hand, hydrogels prepared with 
polymer concentrations below 30 wt% deswelled significantly in PEG-based solution. 
Both 30 and 35 wt% PVA hydrogels maintained swelling ratios close to one throughout 
the study in osmotic solution.  
 
Interestingly, the number of freeze-thaw cycles did not affect hydrogel swelling behavior 
at equilibrium in either medium, as seen in Figures 4.21 to 4.24. Equilibrium water 
contents ranged between 64.9 ± 1.5% and 89.2 ± 0.2% and 61.0 ± 0.8% and 70.2 ± 0.7% 
for non-osmotic and osmotic solution respectively. The same trends with polymer 
concentration, swelling medium osmotic pressure, and PVA swelling ratio as observed 
previously in Figures 4.19 and 4.20 are also observed in Figures 4.23 and 4.24. After 
swelling in both non-osmotic and osmotic solution for 28 days, PVA hydrogels were 
characterized in tension, WAXD, and using optical imaging to determine the effects of 
swelling on hydrogel material properties.  
 
4.4.4.2. Tensile modulus 
The tensile modulus of freeze-thawed hydrogels as a function of initial polymer 
concentration and freeze-thaw cycles was characterized after swelling for 28 days in both 
non-osmotic (0 atm) and osmotic solution (0.95 atm), as shown in Figure 4.25 and Figure 
4.26 respectively. For samples immersed in either solution, increases in modulus were 
observed through six freeze-thaw cycles similar to trends observed before swelling (p < 
0.05). Polymer concentration also had a significant effect on tensile modulus after 
swelling, where higher initial polymer concentrations had a higher tensile modulus, with 
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the exception of between 30 and 35 wt% PVA and between 10 and 20 wt% PVA made 
with four freeze-thaw cycles in osmotic solution (p < 0.05). The effect of polymer 
concentration, however, was more pronounced in non-osmotic solution.  
 
After swelling in non-osmotic solution (0 atm), hydrogels with 30 and 35 initial wt% 
PVA experienced decreases in tensile modulus, hydrogels with 20 initial wt% PVA 
experienced little change, and hydrogels with 10 initial wt% PVA experienced increases 
in tensile modulus (Figure 4.25). This corresponds well to the trends observed in swelling 
ratio. In general, samples that swelled had a lower tensile modulus and that deswelled had 
a higher tensile modulus after 28 days in vitro using non-osmotic solution.  
 
For samples swelling in osmotic solution (0.95 atm), statistically significant increases in 
tensile modulus were observed for all formulations regardless of swelling ratio (p < 0.05). 
This is of particular note since hydrogels with initial polymer concentrations of 30 and 35 
wt% PVA did not swell or deswell significantly. 
 
For formulations tested, the tensile modulus ranged between 0.11 ± 0.01 to 0.53 ± 0.03 
MPa and 0.32 ± 0.03 to 0.93 ± 0.02 MPa for hydrogels swollen in non-osmotic and 
osmotic solution respectively. The tensile modulus range for the same formulations 
before swelling was 0.04 ± 0.01 to 0.78 ± 0.05 MPa. Tensile modulus values before and 
after swelling are summarized in Table 4.2 where * and ** denotations are made for 
samples that experienced significant deswelling (swelling ratio < 0.9) and swelling 
(swelling ratio > 1.1) respectively.  
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4.4.4.3. Crystallinity  
The relative crystallinity of freeze-thawed hydrogels as a function of initial polymer 
concentration and freeze-thaw cycles was characterized after swelling for 28 days in both 
non-osmotic (0 atm) and osmotic solution (0.95 atm), as shown in Figure 4.27 and Figure 
4.28 respectively. Crystallinity was determined using WAXD, as described previously. 
Increases in crystallinity, or aging, were observed for all sample formulations in both 
osmotic and non-osmotic solution (p < 0.05). Aging has been reported previously to 
occur to freeze-thawed PVA hydrogels when in solution [61]. Higher increases in 
crystallinity, regardless of swelling ratio and hydrogel formulation, were observed in 
osmotic solution (p < 0.05). Relative crystallinity was found to vary between 2.69 ± 0.17 
to 6.29 ± 0.79% and 6.54 ± 0.55 to 7.98 ±0.39% for non-osmotic and osmotic solution 
respectively.  
 
Similar trends in crystallinity, as a function of initial polymer concentration and freeze-
thaw cycling, were observed after swelling in non-osmotic solution as trends observed 
before swelling (Figure 4.27). In particular, statistically significant differences were 
noted between two and four cycles (three freeze-thaw cycles was not evaluated) and with 
increasing polymer concentration (p < 0.05). Interestingly, no dependence of either initial 
polymer concentration or number of freeze-thaw cycles was noted on crystallinity in 
osmotic-solution (Figure 4.28) (p > 0.05). Crystallinity values before and after swelling 
are summarized in Table 4.2 where * and ** denotations are made for samples that 
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experienced significant deswelling (swelling ratio < 0.9) and swelling (swelling ratio > 
1.1) respectively. 
 
4.4.4.4. Microstructure 
The microstructure of freeze-thawed hydrogels, as a function of initial polymer 
concentration and freeze-thaw cycles, was characterized after swelling for 28 days in 
both non-osmotic (0 atm) and osmotic solution (0.95 atm), as shown in Figure 4.29 and 
Figure 4.30 respectively. In general, the same type of pore structure was observed after 
swelling in vitro in either solution. Figure 4.31 shows a comparison of hydrogel 
microstructure before swelling and after swelling in non-osmotic and osmotic solution for 
hydrogels synthesized with four freeze-thaw cycles. In this figure, it is clear that sample 
formulations that deswelled and swelling in vitro also experienced decreases and 
increases in porosity respectively. 
 
4.5. Discussion 
Non-degradable physically cross-linked freeze-thawed PVA hydrogels offer the 
biocompatibility [9,68,97] and mechanical properties needed for soft tissue applications. 
In this work, the compressive and tensile modulus of PVA freeze-thawed hydrogels was 
evaluated as a function of both freeze-thaw cycles and polymer content. Linear trends for 
both compressive and tensile modulus were observed with freeze-thaw cycles through the 
first six cycles. Polymer content was also seen to have a significant effect on modulus (p 
< 0.05). The compressive modulus was shown to vary between 0.0012 ± 0.0005 and 0.85 
± 0.04 MPa. This modulus range includes values reported for the aggregate compressive 
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modulus of various cartilage tissues, including the meniscus (0.22MPa) [87], the 
temporomandibular joint (TMJ) disk (16–29 kPa) [88], articular cartilage (0.53–1.82 
MPa) [89], and others (Table 2.2). As expected, the tensile modulus of freeze-thawed 
PVA hydrogels without any fibrous reinforcement was much lower than cartilaginous 
and fibrous tissues. 
 
Significant research is reported in the literature suggesting the formation of physical 
cross-links during cycling, primarily crystallites, allow the PVA hydrogel network to 
carry increased load [29,46-48]. Physical cross-links are formed between the PVA chains 
in the form of hydrogen bonding and crystallization. As the water within the sample 
freezes, regions of very high PVA concentration form, bringing the PVA chains into 
close contact and allowing for the formation of cross-links. Bound water and relative 
crystallinity were measured in order to understand the effect of cross-linking on modulus 
for freeze-thawed hydrogels. Both studies reported similar results; decreases in bound 
water and increases in crystallinity were observed in the first few cycles with no changes 
after three cycles (p < 0.05). Statistical differences, however, were noted through the first 
six cycles in modulus for all polymer concentrations. This suggests the presence of 
additional mechanisms contributing to modulus beyond crystallization.  
 
Structural remodeling of PVA domains for freeze-thawed hydrogels was observed with 
increased cycling. During remodeling, regions of high concentration of PVA formed. The 
formation of highly concentrated regions of amorphous, uncross-linked PVA chains with 
cycling is a potential factor contributing to the trends observed in the compressive and 
 86 
tensile modulus. It is possible that regions of highly concentrated PVA increase the load-
bearing ability of the hydrogels, independently of cross-linking. 
 
Phase separation is a crucial and unique mechanism that occurs during freeze-thawed 
PVA hydrogel gelation and facilitates the formation of crystalline regions. Several 
researchers have shown evidence of phase separation through imaging of the PVA 
microstructure [46,98]. Nonetheless, little to no research has tried to elucidate the impact 
phase separation has on PVA material properties. To investigate the impact of phase 
separation on PVA hydrogel formation, freeze-thawed hydrogels were compared to aged 
hydrogels without any freeze-thaw cycling. Aqueous PVA solutions undergo aging, or 
crystallization, at room temperature without any external influences [50,65,66]. Of note, 
in synthesizing aged hydrogels without any freeze-thaw cycling, the mechanism in which 
phase separation occurs for freeze-thawed hydrogels does not exist. Comparison between 
freeze-thawed and aged PVA hydrogels allowed for insight into the relative importance 
of crystallization versus phase separation and PVA densification for hydrogel mechanical 
properties. As expected, the gross appearance (Figure 4.9) and optical micrographs 
(Figure 4.18) of aged PVA hydrogels did not show any evidence of phase separation. 
Furthermore, both modulus and crystallinity were lower for aged hydrogels indicating the 
importance of freeze-thaw cycling for crystallite formation (p < 0.05). Table 2.1 
summarizes various properties for both aged and freeze-thawed PVA hydrogels.  
 
In order to differentiate crystallinity and phase separation, crystallinity and modulus 
values were compared between aged hydrogels and freeze-thawed hydrogels after six 
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cycles as shown in Figure 4.32. Only freeze-thawed hydrogels after six cycles considered 
for comparison since changes in phase separation were most significant after three cycles 
when crystallization was no longer changing. Figure 4.32 clearly shows higher modulus 
values for freeze-thawed hydrogels compared to aged hydrogels when comparing 
samples of similar crystallinity (p < 0.05). This confirms the presence of two separate 
mechanisms contributing to modulus for freeze-thawed hydrogels; where the formation 
of crystallites occurs initially and is followed by PVA phase separation and densification 
at later cycles. The exact importance of each mechanism during the first three cycles is 
unknown. 
 
In vitro studies were performed in osmotic (0.95 atm) solutions mimicking the swelling 
pressure of articular cartilage in the knee and compared with the typical in vitro swelling 
medium, PBS (0 atm). For soft tissue applications, limited volume changes are desirable 
to ensure the biomaterial matches the size of the tissue replaced. Furthermore, in the case 
of hydrogel composites controllable volume changes are required to prevent interfacial 
debonding. Thus, the use of an appropriate swelling medium to mimic the in vivo 
environment is critical to characterize and predict the behavior of hydrogels to be used as 
tissue replacements or tissue-engineered scaffolds.  
 
In osmotic solution (0.95 atm) hydrogels exhibited decreased equilibrium water contents 
compared with gels in non-osmotic solution (0 atm) (p < 0.05), showing the importance 
of knowing the model tissue swelling pressure for in vitro testing. Decreased equilibrium 
hydration is expected for samples in osmotic solution due to an increase in pressure 
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observed by the samples. Swelling behavior was also found to be a strong function of 
initial polymer concentration. With increasing polymer concentration the swelling ratio 
was also observed to increase for all hydrogel formulations tested (p < 0.05). This is a 
result of an increase in hydrogel swelling pressure with increasing polymer concentration. 
Limited swelling in vitro was observed for hydrogels with a polymer concentration of 20 
wt% PVA in non-osmotic solution and between 30 and 35 wt% PVA in osmotic solution 
with a pressure of 0.95 atm. The ability of PVA hydrogels to exhibit limited swelling in 
both solutions tested suggests that the initial polymer concentration can be modulated to 
control swelling behavior in vivo over a range of osmotic pressures.  
 
In addition, no significant effects of the number of freeze-thaw cycles on swelling ratio 
were observed after four weeks in vitro (p > 0.05). Increases in cross-linking, known to 
occur with increases in freeze-thaw cycling, would cause decreases in chain mobility and 
the ability of a matrix to swell [29,46-48]. On the other hand, increases in porosity 
augment the rate of diffusion into the matrix, increasing swelling. These mechanisms 
appear to offset one another in the case of physically cross-linked PVA hydrogels. It is 
also possible the strong dependence of swelling behavior on initial polymer concentration 
negates the impact of other contributing factors. The independence of freeze-thaw cycles 
on swelling behavior indicates that the mechanical and microstructural properties of PVA 
hydrogels can be varied by changing the number of freeze-thaw cycles without affecting 
the swelling properties determined by polymer concentration. The composition and 
processing parameters of PVA hydrogels can thus be modulated to match both a specific 
swelling ratio and a specific modulus or porosity. This was confirmed through tensile 
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testing after swelling for 28 days in vitro in both osmotic and non-osmotic solution, 
where increases in modulus with freeze-thaw cycling were still observed through six 
cycles (p < 0.05). 
  
The impact of swelling on hydrogel microstructure and crystallinity was also determined 
after 28 days in vitro in non-osmotic and osmotic solution. Of particular note, aging, or 
crystallization, occurred in solution for all samples with significantly more crystallization 
occurring in osmotic solution (p < 0.05). The application of an external load significantly 
contributes to crystallization in vitro. This was also reflected when evaluating tensile 
modulus after swelling, where significant increases were present after swelling in osmotic 
solution for all sample formulations regardless of hydrogel swelling ratio. Furthermore, 
no significant trends for crystallinity were observed as a function of freeze-thaw cycling 
or initial polymer concentration after swelling in osmotic solution. This is particularly 
important as tensile modulus was dependent on both the number of freeze-thaw cycles 
and initial polymer concentration after swelling (p < 0.05), further indicating that 
modulus is dependent on other factors besides crystallinity.  
 
Changes in hydrogel microstructure after 28 days in vitro were primarily dependent on 
swelling ratio regardless of swelling medium or pressure. In general samples that 
deswelled indicated decreases in hydrogel pore structure and those that swelled 
experienced increases in pore structure. Changes in hydrogel microstructure are believed 
to play an important role in hydrogel mechanical properties, as described previously. All 
of the results before and after swelling are summarized in Table 4.2 where * and ** 
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denotations are made for samples that experienced significant deswelling (swelling ratio 
< 0.9) and swelling (swelling ratio > 1.1) respectively. 
 
4.6. Conclusions 
Physically cross-linked PVA hydrogels possess the biocompatibility and mechanical 
properties needed for many soft tissue applications [7,67,72]. The compressive modulus 
of PVA freeze-thawed hydrogels varied between 0.0012 ± 0.0005 and 0.85 ± 0.04 MPa, 
similar to the aggregate compressive modulus values reported for meniscal, articular, and 
TMJ cartilage [90]. Two separate mechanisms were found to occur during freeze-thaw 
cycling, crystallization and phase separation, and contribute to hydrogel modulus. 
Crystallization occurred at early freeze-thaw cycles (1-3 cycles) and phase separation and 
PVA densification occurred through at least six cycles. This finding has noteworthy 
implications, as no literature to date cites phase separation as a significant mechanism 
responsible for PVA hydrogel properties independently of crystallization. An improved 
understanding of the mechanisms that occur during gelation and their impact on hydrogel 
properties will allow for improved material design for biomedical applications. 
Additionally, this work clearly displays the fundamental importance of material 
microstructure on resultant properties.  
 
The effect of osmotic pressure in vitro was evaluated using macromolecular-based 
solutions. This is particularly relevant for tissues present in load-bearing joints with high 
swelling pressures. Results indicate in vitro osmotic pressure drastically alters material 
swelling behavior and material properties. In particular, all hydrogel formulations 
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experienced decreased equilibrium hydration in osmotic pressure solutions compared 
with the typical in vitro swelling medium, PBS (0 atm). Aging, or increases in hydrogel 
crystallinity, were also observed for all samples after swelling. This effect, however, was 
significantly more pronounced after swelling in osmotic solution (p < 0.05) and further 
displays the importance of using the appropriate swelling medium in vitro. Significant 
increases in crystallinity for samples swollen in osmotic-based solution also experienced 
high increases in tensile modulus.  
 
Additionally, swelling behavior was primarily dependent upon initial polymer 
concentration and no significant effect of freeze-thaw cycling on swelling ratio (p < 0.05). 
This allows tailoring of PVA hydrogels through modulation of polymer concentration 
and freeze-thaw cycles to independently achieve a specific swelling ratio and 
compressive modulus for a wide range of desired properties and applications.  
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Figure 4.1: Structural model of PVA hydrogel formed via freeze-thaw cycling. Black 
circles are crystallites [49].   
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Figure 4.2: Hydrogen bonding between PVA and PVP [56].   
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Figure 4.3: Schematic detailing the states of water in PVA hydrogels: bound and 
unbound.  
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Figure 4.4: PVA freeze-thawed hydrogels synthesized with 10, 20, 30, and 35 wt% PVA 
(top to bottom) for 2, 4, and 6 freeze-thaw cycles (left to right). 
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Figure 4.5: Typical stress vs. strain curve for 20 wt% PVA hydrogel following five 
freeze-thaw cycles in compression. The compressive modulus was calculated as the 
average slope of the stress vs. strain curve between 1% and 5% strain. 
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Figure 4.6: Typical stress vs. strain curve for 20 wt% PVA hydrogel following five 
freeze-thaw cycles in tension. The tensile modulus was calculated as the average slope of 
the stress vs. strain curve between 1 and 5% strain. 
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Figure 4.7: Compressive modulus of 10, 20, 30, and 35 wt% PVA hydrogels with 
increasing freeze-thaw cycles. Increases in modulus were observed through the first six 
cycles (p < 0.05). Trend lines (- - -) represent a linear best fit through the first six cycles 
followed by the average value within the plateau region. 
 
 
 
 
 99 
 
 
 
Figure 4.8: Tensile modulus of 10, 20, 30, and 35 wt% PVA hydrogels with increasing 
freeze-thaw cycles. Increases in modulus were observed through the first six cycles (p < 
0.05). Trend lines (- - -) represent a linear best fit through the first six cycles followed by 
the average value within the plateau region. 
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Figure 4.9: PVA aged hydrogels synthesized with 30 and 35 wt% PVA (top to bottom) 
aged for periods of up to 31 days (left to right). 
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Figure 4.10: Compressive modulus of 30 and 35 wt% PVA hydrogels with increasing 
aging time. 
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Figure 4.11: Typical DSC ice melting curve for PVA hydrogels.  
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Figure 4.12: Bound water as a function of freeze-thaw cycles determined using DSC. 
Decreases in the amount of bound water present in PVA hydrogels with cycling indicates 
hydrogen bonding is occurring between PVA chains. 
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Figure 4.13: Typical wide-angle X-ray diffraction spectra for 30 wt% PVA hydrogels 
with increasing freeze-thaw cycles. 
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Figure 4.14: Relative crystallinity of 10, 20, 30, and 35 wt% PVA hydrogels with 
increasing freeze-thaw cycles. Increases in relative crystallinity were observed through 
the first three cycles (p < 0.05). Trend lines (- - -) represent a linear best fit through the 
first three cycles followed by the average value within the plateau region. 
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Figure 4.15: Relative crystallinity of 30 and 35 wt% PVA hydrogels as a function of 
aging time. 
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Figure 4.16: Micrographs of freeze-thawed PVA hydrogels in the hydrated state show 
that structural remodeling occurs with increasing freeze-thaw cycling and polymer 
concentration, in the form of polymer densification. Scale bars indicate 80 μm.  
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Figure 4.17: Porosity of 10, 20, 30, and 35 wt% PVA hydrogels showing a progressive 
increase in porosity with freeze-thaw cycles through at least four cycles (p < 0.05). 
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Figure 4.18: Micrographs of aged PVA hydrogels do not show structural remodeling or 
phase separation with aging or polymer concentration. Scale bars indicate 80 μm.  
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Figure 4.19: In vitro swelling behavior as a function of time for PVA hydrogels 
synthesized with five freeze-thaw cycles in non-osmotic solution (0 atm). All samples 
reached equilibrium after two weeks in solution. 
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Figure 4.20: In vitro swelling behavior as a function of time for PVA hydrogels 
synthesized with five freeze-thaw cycles in osmotic solution (0.95 atm). All samples 
reached equilibrium after two weeks in solution. 
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Figure 4.21: Equilibrium water content for PVA hydrogels prepared as a function of both 
polymer concentration and freeze-thaw cycles following 28 days in non-osmotic solution 
(0 atm). Swelling behavior was found to be independent of the number of freeze-thaw 
cycles. 
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Figure 4.22: Equilibrium water content for PVA hydrogels prepared as a function of both 
polymer concentration and freeze-thaw cycles following 28 days in osmotic solution 
(0.95 atm). Swelling behavior was found to be independent of the number of freeze-thaw 
cycles. 
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Figure 4.23: In vitro swelling behavior for PVA hydrogels prepared as a function of both 
polymer concentration and freeze-thaw cycles following 28 days in non-osmotic solution 
(0 atm). Swelling ratio was found to be independent of the number of freeze-thaw cycles. 
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Figure 4.24: In vitro swelling behavior for PVA hydrogels prepared as a function of both 
polymer concentration and freeze-thaw cycles following 28 days in osmotic solution 
(0.95 atm). Swelling ratio was found to be independent of the number of freeze-thaw 
cycles. 
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Figure 4.25: Tensile modulus of freeze-thawed PVA hydrogels after swelling in non-
osmotic solution (0 atm) for 28 days as a function of both initial polymer concentration 
and number of freeze-thaw cycles. Increases in modulus were still observed with 
increased cycling (p < 0.05).  
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Figure 4.26: Tensile modulus of freeze-thawed PVA hydrogels after swelling in osmotic 
solution (0.95 atm) for 28 days as a function of both initial polymer concentration and 
number of freeze-thaw cycles. Increases in modulus were still observed with increased 
cycling (p < 0.05).  
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Figure 4.27: Relative crystallinity of freeze-thawed PVA hydrogels after swelling in 
non-osmotic solution (0 atm) for 28 days as a function of both initial polymer 
concentration and number of freeze-thaw cycles. 
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Figure 4.28: Relative crystallinity of freeze-thawed PVA hydrogels after swelling in 
osmotic solution (0.95 atm) for 28 days as a function of both initial polymer 
concentration and number of freeze-thaw cycles. 
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Figure 4.29: Micrographs of freeze-thawed PVA hydrogels after swelling in non-osmotic 
solution (0 atm) for 28 days as a function of both initial polymer concentration (top to 
bottom) and number of freeze-thaw cycles (left to right). Scale bars indicate 80 μm.  
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Figure 4.30: Micrographs of freeze-thawed PVA hydrogels after swelling in osmotic 
solution (0.95 atm) for 28 days as a function of both initial polymer concentration (top to 
bottom) and number of freeze-thaw cycles (left to right). Scale bars indicate 80 μm.  
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Figure 4.31: Comparison between micrographs of freeze-thawed PVA hydrogels 
synthesized with four freeze-thaw cycles before swelling (fresh) and after swelling in 
non-osmotic solution (0 atm) and osmotic solution (0.95 atm) for 28 days as a function of 
initial polymer concentration (top to bottom). Scale bars indicate 80 μm.  
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Figure 4.32: Dependence of modulus on crystallinity of freeze-thawed and aged PVA 
hydrogels. Crystallinity plotted for freeze-thawed hydrogels after six cycles. Results 
indicate higher modulus for freeze-thawed hydrogels with similar crystallinity compared 
to aged hydrogels (p < 0.05).  
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Table 4.1: Average compressive modulus, tensile modulus, crystallinity, and porosity for 
freeze-thawed and aged PVA hydrogels as a function of polymer concentration. 
 
a Values are after 6 cycles for freeze-thawed hydrogels and 31 days for aged gels 
b
 Values are after 3 cycles for freeze-thawed hydrogels and 31 days for aged gels 
 
 
 
  
 
Compressive 
Modulus (MPa)
a 
Tensile 
Modulus (MPa)
a 
Crystallinity 
(%)
b Porosity (%)
a 
Freeze-Thawed 
Hydrogels 
    
10% PVA 0.070 ± 0.008 0.066 ± 0.007 0.36 ± 0.12 45.1 ± 5.4 
20% PVA 0.241 ± 0.010 0.224 ± 0.024 1.48 ± 0.23 44.8 ± 3.3 
30% PVA 0.678 ± 0.030 0.774 ± 0.044 3.59 ± 0.36 36.4 ± 5.3 
35% PVA 0.801 ± 0.040 1.018 ± 0.007 5.20 ± 0.43 36.2 ± 3.6 
Aged 
Hydrogels 
    
30% PVA 0.343 ± 0.097  2.35 ± 0.38 1.3 ± 0.7 
35% PVA 0.408 ± 0.072  3.80 ± 1.80 2.2 ± 1.3 
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Chapter 5: Improve stress transfer and interfacial shear strength at the fiber-matrix 
interface 
 
5.1. Introduction 
Physically cross-linked PVA hydrogels are extremely biocompatible [1], possess similar 
viscoelastic properties compared to articular [2,3] and meniscal cartilage [4], and do not 
exhibit any wear even after millions of cycles [5]. As a result, PVA hydrogels have been 
investigated extensively for articular cartilage applications [6,7]. Poor properties in 
tension, however, limit the actual use of this material, especially for stronger fibrous 
tissues like the meniscus. In order to improve tensile properties, PVA hydrogels were 
reinforced with ultra high molecular weight polyethylene (UHMWPE) fibers. 
 
Strong and stiff fibers are needed to withstand the hoop stresses that occur during gait 
and to allow for fixation. UHMWPE fibers are biocompatible and possess high strength, 
tensile modulus, and fatigue resistance [8,9]. Due to these properties, UHMWPE fibers 
can be used to not only reinforce PVA hydrogels, but also to secure the implant in place 
during surgery. The hydrophobic nature of UHMWPE, however, requires surface 
modification to improve wetting of the fibers and prevent fiber-matrix debonding.  
 
In this work, oxygen plasma treatments and a novel chemical grafting technique were 
performed on UHMWPE fibers to increase interfacial adhesion. The chemical grafting 
technique utilized the hydroxyl groups on the fiber surfaces after plasma treatment to 
chemically graft PVA directly onto UHMWPE. PVA-grafted-UHMWPE fibers were then 
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physically cross-linked into the hydrogel network. Single fiber pull-out tests were used to 
calculate interfacial shear strength as a quantitative measure of interfacial adhesion. 
Interfacial shear strength was determined as a function of oxygen plasma treatment time, 
degree of chemical grafting, and fiber spacing. Scanning electron microscopy (SEM) was 
used to determine the mode of failure after fiber pull-out. The biocompatibility of PVA-
grafted-UHMWPE fiber mats was confirmed using a cell-based in vitro cytotoxicity test.   
 
5.2. Background 
Several methods have been used previously to enhance the mechanical properties of 
polymer networks. This includes both alteration of the polymer network itself, such as 
through additional crystallization [10] or the creation of a double network [11,12], and 
the addition of various additives, such as fibers [13,14], clays [15], and nanotubes [16,17]. 
Fiber-based composites offer the advantage of easily imparting anisotropic properties to 
the material. Additionally, for meniscal applications, cues can be taken from nature and 
the inherent orientation of collagen fibers within the meniscus to lead design and mimic 
the native structure of human meniscal tissue [18,19,20].  
 
5.2.1. UHMWPE fibers 
Strong and stiff fibers are needed to withstand the intense hoop stresses produced during 
gait and to allow for fixation. High strength fibers previously used in biomedical 
applications include: carbon [21,22], aramid [23,24], and UHMWPE fibers [25,26]. 
Carbon fibers suffer from poor shear strength and wear resistance [9]. As a result, use of 
carbon fiber-based composites in the clinic has produced negative results [27,28]. Aramid 
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fibers, such as Kevlar®, possess high damage and fatigue resistance; however, significant 
water absorption limits their use for biomedical applications [9]. Uncontrolled fiber 
swelling can produce residual stresses within the composite and cause material failure.  
 
UHMWPE fibers, on the other hand, are extremely biocompatible, have superior abrasion 
and fatigue resistance, and do not absorb water [8,9]. The inert and hydrophobic nature of 
UHMWPE fibers, nevertheless, presents a challenge regarding composite manufacturing 
and processing due to poor fiber wettability and interfacial adhesion. As such, surface 
modification of UHMWPE fibers is generally required. UHMWPE fibers have been used 
as reinforcement for dentistry [29], intervertebral disc [30], and ligament applications 
[31].   
 
5.2.2. Plasma surface modification 
Surface modification techniques seek to tailor the surface properties of materials without 
affecting bulk material properties and can involve modification of the existing material 
surface or coating the surface with a new material [32]. Techniques that modify the 
existing surface include etching, surface topography and patterning, and cross-linking 
[32]. Modifying material surfaces using different materials include: radiation-based 
techniques [33,34], chemical grafting [35,36], sizing [37,38], the use of coupling agents 
[39,40], and plasma treatments [41,42]. These techniques can alter material wettability, 
permeability, stability, inertness, adhesion, biocompatibility, topography, conductivity, 
and frictional properties, among others [21]. For improved fiber-matrix adhesion, plasma 
treatments and chemical grafting are of particular interest.  
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Plasma is a highly reactive, excited ionized gas consisting of various atoms, molecules, 
ions, and radicals. Due to plasma’s high reactivity, it is effective even on inert surfaces 
[21]. Plasma alters material surfaces through etching, cross-linking, oxidation, and 
chemical deposition [44,45]. Depending on the type of plasma used, specific 
functionalities can be introduced onto the material surface. Plasma treatments can 
enhance a wide range of material surface properties, such as: biocompatibility, adhesion, 
wettability, conductivity, and roughness, among others [43]. The advantages of plasma 
surface modification techniques compared to other methods include: high throughput, 
control over resulting surface chemistry, relatively uniform treatment, dry processing, 
environmentally friendly, no waste disposal, low cost, and the treatment is confined to the 
surface [32,43,46].  
 
A number of factors impact plasma generation: discharge source (radio frequency, 
microwave, glow, arc, dielectric barrier, corona, etc.), experimental configuration, 
pressure, gas, flow rate, and interelectrode gap to name a few [46]. For polymers, low-
pressure glow and corona discharge systems have been predominately used [47,48]. Low-
pressure plasma, however, requires a vacuum and can be costly. Recently, the use of 
atmospheric pressure dielectric barrier discharge (DBD) plasma has emerged, as it is just 
as effective and more economical [46].  
 
To increase interfacial adhesion, plasma surface modification of polyethylene fibers has 
used a variety of gas sources, including: nitrogen [49], oxygen [50], argon [51], ammonia 
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[52], helium [53], air [54], and combinations thereof [55]. In particular, Yim evaluated 
the effect of atmospheric pressure DBD plasma on UHMWPE fibers using a variety of 
gases, gas flow rates, and treatment times. Characterization techniques included X-ray 
photoelectron spectroscopy (XPS) and atomic force microscopy (AFM) to determine 
chemical composition on fiber surfaces and surface roughness following plasma 
treatment. Results indicated an increase in both surface roughness, Figure 5.1, and 
oxygen-containing groups (hydroxyl, carbonyl, and carboxyl) on the fiber surface, Figure 
5.2, following plasma treatment [46]. This is in agreement with other studies 
documenting the impact of plasma treatments on UHMWPE fibers [56,57]. The presence 
of oxygen-containing groups improves fiber wettability [46,56]. Furthermore, roughening 
of fiber surfaces contributes to mechanical interlocking at the fiber-matrix interface 
[56,57]. Together, this allows for improved interfacial adhesion through both mechanical 
interlocking and chemical bonding. Due to the presence of reactive groups on the fiber 
surface following plasma treatment, chemical grafting of specific functional groups is 
possible following treatment. Chemical grafting can further increase interfacial adhesion 
through the formation of a covalent linkage between the fiber and matrix.   
 
5.3. Materials and methods 
5.3.1. PVA shear strength 
PVA hydrogels were evaluated in shear, to determine the upper limit for interfacial shear 
strength. Cylindrical hydrogel samples approximately 12 mm in diameter were 
synthesized according to section 4.3.1 using 20 wt% PVA and five freeze-thaw cycles 
(n=5). PVA samples were held in place using a two-piece plastic in-house designed 
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apparatus shown in Figure 5.3(a). Each plastic piece had a 12 mm diameter indentation. 
The hydrogels were inserted into the apparatus such that the plastic surfaces for both 
pieces touched each other. Tensile grips were used to secure the plastic surfaces in place. 
Testing was performed using an Instron Materials Testing System Series 4442 (Norwood, 
MA) with a 500 N load cell at a constant crosshead speed, 10 mm per min, perpendicular 
to the hydrogel’s axial axis. Testing conditions were in air at room temperature and 
performed until failure. Failure occurred along the radial axis as shown in Figure 5.3b. A 
free-moving metal ring was placed around the two pieces to constrain movement of the 
plastic to the testing direction. Shear strength, τmax, PVA, was calculated as maximum load 
over cross-sectional hydrogel area according to equation 5.1:  
 
τmax     A 
 max
  2
  (5.1) 
 
where Fmax is load at failure and r is hydrogel radius.   
 
5.3.2. UHMWPE fibers 
UHMWPE fibers with a fiber diameter of approximately 25 μm were obtained from Fiber 
Materials, Inc. (Biddeford, ME). Fibers were obtained under trade name Spectra® 1000 
in plain weave style 945 with a denier of 215 and reported fiber strength and modulus of 
3.25 and 113 GPa respectively. Single UHMWPE fibers were manually separated from 
fiber bundles in the weave.   
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5.3.3. UHMWPE fiber morphology 
Scanning electron microscopy (SEM; Model FEI/Phillips XL30) was used to image 
UHMWPE fiber surfaces. Samples were carbon coated to prevent charging. Low beam 
energy, 3 kV, was used to prevent sample destruction during imaging.  
 
5.3.4. Oxygen plasma treatment  
Oxygen plasma treatments were performed to increase adhesion at the fiber-matrix 
interface. Room temperature atmospheric pressure dielectric barrier discharge oxygen 
plasma at 1 W/cm
2
 was used to produce oxygen-containing groups onto UHMWPE fiber 
surfaces, including carboxyl, carbonyl, and hydroxyl groups [46]. The plasma reactor 
used is shown in Figure 5.4. Reactor specifications are summarized in Table 5.1 and are 
detailed elsewhere [46]. Treatment times were varied from 0 to 9 minutes for UHMWPE 
fibers at a constant flow rate of 1 liter per minute (LPM) O2.  
 
5.3.5. PVA grafting 
PVA is known to react with aldehydes via an acid catalyzed acetal bridge reaction 
[58,59]. To further improve adhesion, PVA-aldehyde chemistry was used to develop a 
method to create a covalent link between UHMWPE fibers and PVA, where Figure 5.5 
shows the theoretical reaction scheme. Aldehyde functionalization of UHMWPE fibers 
was performed on plasma treated fibers by submersion in 5-20 wt% glutaraldehyde 
solution with an acid catalyst for periods of up to 18 hours at room temperature. 
Following a wash step, PVA was grafted onto fiber surfaces by immersing aldehyde 
functionalized fibers in 10 wt% PVA with an acid catalyst and allowed to react overnight. 
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A lower concentration of PVA was used to allow for more mobility during the grafting 
process. PVA-grafted UHMWPE fibers (PVA-g-UHMWMPE) were washed in deionized 
water at 400 rpm for periods of up to 18 hours with water changes every two hours. In 
some cases, an additional hour of washing was performed under ultrasound. Fiber mass 
was measured before and after PVA grafting in the hydrated state (n=4). SEM was 
performed as described previously to characterize fiber surface morphology after 
chemical grafting.  
 
5.3.6. Fiber pull-out test  
Cylindrical samples containing single UHMWPE fibers embedded in PVA were used to 
measure interfacial shear stress. An Instron Materials Testing System Series 4442 
(Norwood, MA) with a 50 N load cell was used to record the load required to pull the 
fiber out of the hydrogel. Instead of gripping the fiber directly during testing, the 
UHMWPE fiber end was threaded through a capillary tube and adhered inside of the tube 
using Loctite adhesive. A cotter pin was used to grip the capillary tube and adhered to the 
tube as well. Tensile grips were used to grip the cotter pin and pull the single fiber from 
the hydrogel. The experimental set-up and testing procedure is shown in Figure 5.6. The 
tests were performed in air at room temperature using a crosshead speed of 50 mm per 
min. Each fiber was embedded approximately 20-30 mm in PVA. The equation used for 
calculation of interfacial shear strength (IFSS), τmax, is shown in equation 5.2, where Fmax 
is the maximum force required to pull the fiber from the hydrogel, D is fiber diameter, 
and L is embedded fiber length [60]. Fiber diameter was approximated as 25 μm based on 
microscopy measurements. Tests were performed on untreated, plasma treated, and PVA-
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grafted fibers as a function of treatment conditions. Plasma treated samples were treated 
for 3, 6, or 9 minutes. PVA-grafted samples were exposed to 5, 10, and 20 wt% 
glutaraldehyde for 2, 6, and 18 hours according to section 5.3.5. Fiber pull-out samples 
were made using 20 wt% PVA and subjected to five freeze-thaw cycles.  
 
 
  (5.2) 
 
Additionally, stress on the fiber, σfiber, during fiber pull-out testing was approximated 
using equation 5.3, where F is the force measured during pull-out and r is fiber radius. 
 
 fi e  
 
  2  (5.3) 
 
In order to determine the effect of spacing between individual fibers, fiber pull-out tests 
were also performed on fiber bundles as received from the manufacturer (60 individual 
fibers), three fibers with no spacing, and three fibers spaced two mm apart in a triangular 
formation. This was performed for untreated and PVA-grafted samples and compared to 
single fiber pull-out tests. IFSS for all samples was corrected according to the number of 
fibers present, n, according to equation 5.4. Figure 5.7 shows a schematic of the different 
fiber spacings tested. SEM was performed as described previously to characterize failure 
mode after fiber pull-out as a function of treatment type.  
 
τmax  
 max
   n
 
  (5.4) 
  
tmax =
Fmax
pDL
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5.3.7. In vitro cytotoxicity 
Unfortunately, even small concentrations of glutaraldehyde are cytotoxic. Sun et al. 
showed glutaraldehyde decreased cell activity for concentrations as low as 1 mM, Figure 
5.8 [61]. In vitro cytotoxicity of PVA-g-UHMWPE fibers was determined according to 
ISO 10993-5. Briefly, PVA-grafted fiber mats, approximately 0.1 g in size, were placed 
in 0.5 ml of sterile phosphate buffered saline (PBS) solution for three days. This allowed 
for the fiber mats to be fully immersed in solution. Fiber mats were sterilized for one 
hour in 70% ethanol before placing in PBS solution. Sample extracts were taken every 24 
hours and the PBS was replaced. In vitro cell viability of the sample extracts was 
assessed using a cell proliferation assay. An established fibroblast cell line, L929, 
(American Type Culture Collection, ATCC) was used. L929 cells were incubated using 
serum-free media at a concentration of 5,000 cells/well in a 96-well tray for 24 hours 
prior to the addition of sample extracts to allow for cells to adhere. Fifty microliters of 
the sample extract was added to each well and incubated for an additional 72 hours. Cells 
were incubated at 37 °C and 5% CO2 throughout the study. After incubation, cell 
viability was determined using the Cell TiterBlue assay (Promega, Madison, WI) by 
recording fluorescence at excitation 560 nm/emission 590 nm. Fiber mats were prepared 
using one of the highest glutaraldehyde exposures studied in this work, 20 wt% 
glutaraldehyde for six hours. Degree of washing was varied from 0 to 18 hours with 
water changes occurring every two hours to determine the minimal washing required. 
Furthermore, the effect of an additional hour of washing under ultrasound was also 
evaluated. Results were compared to sample extracts from untreated fibers and pure PBS.  
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All samples (n = 3) were assayed in triplicate. 
 
5.3.8. Statistical analysis 
All values are reported as means ± standard deviation for at least three independent 
samples. Statistical analysis was performed using a one-way analysis of variance 
(ANOVA) followed by a Bonferroni post hoc test with a 95% confidence interval (p < 
0.05) to compare mean values. 
 
5.4. Results 
5.4.1. PVA Shear Strength 
A typical load versus extension curve for PVA hydrogels loaded in shear is shown in 
Figure 5.9 and indicates a hyperelastic response. In general, shear failure was noted to 
occur in between 125 and 175 N. This yields a PVA shear strength of 1.42 ± 0.2 MPa, 
using equation 5.1.  
 
5.4.2. PVA grafting 
PVA was successfully grafted onto UHMWPE fibers as shown in Figure 5.10a. Degree 
of PVA coverage was dependent on the grafting conditions, particularly exposure to 
glutaraldehyde. Coverage was defined as either none, partial, or full corresponding to no 
noticeable amounts of PVA on the fiber surface, partial surface coverage, or completely 
covered fiber surfaces respectively. PVA grafting yield as a function of glutaraldehyde 
concentration and exposure time is detailed in Figure 5.10b. The dashed line on the graph 
separates samples that showed partial (below the line) and full (above the line) coverage. 
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Glutaraldehyde exposure affected both surface coverage and grafting yield, where 5 wt% 
reached full coverage at 18 hours, 10 wt% reached full coverage at 4 hours, and 20 wt% 
reached full coverage at two hours. Exposure did not have any noticeable impact on 
grafting yield or surface coverage after full coverage was reached. Of note, grafting 
yields were in the hydrated state and significant water was present within the PVA layer.  
 
PVA grafting was also attempted on UHMWPE fibers using 0 wt% glutaraldehyde; 
however, as shown in Figure 5.10, no grafting occurred and indicates the importance of 
aldehyde functionalization for successful PVA grafting.     
 
SEM was used to confirm aldehyde functionalization after immersion in glutaraldehyde. 
Figure 5.11(b) shows surface roughening following aldehyde functionalization for plasma 
treated samples indicative of successful grafting. It is important to note that no evidence 
of grafting was noticed, as seen in Figure 5.11(a), on non-plasma treated samples 
showing the importance for oxygen-containing groups to be present on the surface for 
functionalization. 
 
5.4.3. Fiber pull-out testing 
Interfacial shear stress was measured using single UHMWPE fiber pull-out tests. A 
single UHMWPE fiber was embedded in PVA and the force required to pull the fiber out 
of the hydrogel was recorded. According to classical shear lag theory proposed by Cox in 
1952 for linear elastic materials [62], a fiber must be embedded at least a critical length, 
lc, in order to achieve maximum shear stress at the interface. This theory assumes a single 
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fiber is in a cylindrical matrix where a perfect bond exists between the fiber and matrix 
and no stress transfer occurs at the ends of the fiber. A simplified version of this model is 
shown in equation 5.5 and allows for calculation of the critical length needed to reach 
maximum interfacial shear stress, where d is fiber diameter and k is a constant [63]. For 
viscoelastic matrices k has been found to be approximately 0.65, which yields an 
approximate critical length of 10 mm for the UHMWPE-PVA system used in this work. 
However, this can vary significantly depending on the fiber and matrix used and the 
degree of bonding at the interface [63]. For the purposes of this study, the minimum 
embedded length allowed was 20 mm to reduce any effects from poor bonding. Critical 
length is known to increase as bonding between the fiber and matrix decreases [63]. To 
ensure maximum interfacial shear stress was reached, dependence between interfacial 
shear strength and embedded length was evaluated for lengths between 20 to 30 mm. No 
dependence was observed in this range, Figure 5.12.  
 
(5.5) 
 
 
A typical fiber pull-out test is shown in Figure 5.13 for both a plasma-treated sample and 
a sample following PVA grafting. The initial peak corresponds to the maximum force 
required to debond the fiber from the matrix. The following force required to pull the 
fiber from the hydrogel is a result of the friction experienced as the fiber slides out of the 
hydrogel. Both debonding force and frictional force increase following PVA grafting.  
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The UHMWPE-PVA interfacial shear strength for PVA-g-UHMWPE fibers and non-
grafted UHMWPE fibers as a function of plasma treatment time is shown in Figure 5.14. 
Increases in interfacial shear strength were observed in both cases with increasing plasma 
treatment time. Without grafting, oxygen plasma treatment increased interfacial shear 
strength from 11.5 ± 2.9 kPa without any treatment to 27.41 ± 5.0 kPa after six minutes 
of treatment. Further increases were observed for all plasma treatment times following 
PVA grafting with interfacial shear strengths reaching 228.6 ± 77.1 kPa for samples 
treated under plasma for six minutes. It is interesting to note that even without plasma 
treatment, PVA grafting resulted in a small increase in IFSS. No difference was observed 
between six and nine minutes of plasma treatment with or without PVA grafting (data not 
shown). Interfacial shear strength as a function of plasma treatment time is summarized 
in Table 5.2.  
 
Glutaraldehyde exposure was also observed to have an effect on interfacial shear strength, 
as depicted in Figure 5.15 and 5.16. Exposure was tailored by modifying glutaraldehyde 
concentration and immersion time. In Figure 5.15 for low immersion times (two hours), 
glutaraldehyde concentration is shown to impact UHMWPE-PVA interfacial shear 
strength. Higher interfacial shear strength is noted with increasing concentration through 
10 wt% glutaraldehyde (p < 0.05). No statistically significant differences were noted 
between 10 and 20 wt% glutaraldehyde. Figure 5.16 details the impact of immersion time 
in 5 and 20 wt% glutaraldehyde. Immersion time was shown to have an effect at low 
glutaraldehyde concentrations, 5 wt% (p < 0.05). However, no statistically significant 
differences were noted at different immersion times for 20 wt% glutaraldehyde.  
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In some cases, after PVA-grafting, failure did not occur at the interface during fiber pull-
out but within the UHMWPE fibers in tension. Figure 5.15 and 5.16 show samples in 
which failure occurred within the fiber as orange data points. These samples were not 
included in interfacial shear strength averages. Fiber strength for these samples was 
calculated using equation 5.3 and the load at fiber failure or the maximum force 
measured. Results indicate a fiber strength of approximately 2 GPa, and in some cases as 
high as 3 GPa, which is similar to reported UHMWPE fiber strength (3.25 GPa).  
 
The effect of spacing between individual UHMWPE fibers on interfacial shear strength 
was also evaluated and compared to single UHMWPE fiber pull-out testing. Fiber 
spacings evaluated include: fiber bundle as received from manufacturer (60 fibers), three 
individual fibers spaced two mm apart in a triangular formation, and three fibers spaced 
zero mm apart. Interfacial shear strength was normalized according to the number of 
fibers in each sample (divided by the number of fibers) as shown in equation 5.3. With 
the exception of the fiber bundle, no statistically significant differences were noted as a 
function of fiber spacing compared to single UHMWPE interfacial shear strength for 
non-grafted fibers (p > 0.05). UHMWPE fiber bundles indicated a high interfacial shear 
strength, 86.9 ± 35.2 kPa, without PVA grafting; however, this value did not increase 
significantly after grafting, 106.0 ± 30.7 kPa. For other fiber spacing formations after 
PVA grafting, spacing was found to have an impact on stress transfer where increases 
were noted with increasing fiber spacing (p < 0.05). These results are summarized in 
Table 5.3.  
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SEM images comparing the UHMWPE fiber surface following fiber pull-out for (a) non-
grafted and (b) PVA-g-UHMWPE fiber samples are shown in Figure 5.17. Both samples 
were subjected to six minutes of oxygen plasma treatment. Although samples without 
grafting do show some evidence of excess polymer on the surface, there is significantly 
more polymer after debonding for grafted samples. More importantly, failure is seen to 
occur at the PVA-UHMWPE interface without grafting and cohesively within the PVA 
matrix after grafting. The inset in Figure 5.17(b) shows the fiber surface underneath the 
polymer shell that remains following debonding. This is another indication that the PVA-
UHMWPE interfacial has been successfully maximized for this system following 
chemical grafting. 
 
5.4.4. In vitro cytotoxicity 
In vitro cell viability was measured after exposure to release extracts in contact with 
UHMWPE fiber samples following glutaraldehyde immersion as a function of wash 
length. Fiber samples were treated with 20 wt% glutaraldehyde for six hours. Washing 
was performed in deionized water for 0, 2, 6, and 18 hours (overnight). The effect of an 
additional hour of washing in ultrasound was also evaluated. PBS release extracts were 
taken after 24, 48, and 72 hours exposure to treated fiber mats. Figure 5.18 and 5.19 show 
normalized cell counts for release extracts as a function of release time point (24, 48, and 
72 hours) and ultrasound washing respectively. Cell counts were normalized using a pure 
PBS sample. As expected improved cell viability was observed for later release time 
points (Figure 5.18) and with washing, particularly with the additional hour of ultrasound 
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(Figure 5.19). Without any washing, sample release extracts were very cytotoxic with a 
cell count of 0.06 ± 0.01. After 18 hours of washing in deionized water and an additional 
hour under ultrasound, the normalized cell count increased to 0.77 ± 0.04 for the 24 hour 
extract time point. Later extract time points showed even higher cell viabilities, up to 
0.97 ± 0.05. Furthermore, Figure 5.19 shows without an hour of washing under 
ultrasound, release extracts after 24 hours resulted in very poor cell viability, 0.07 ± 0.02, 
regardless of time spent washing in water.   
 
5.5. Discussion 
PVA grafting, using the technique detailed in Figure 5.5(b), was successful as confirmed 
by measuring PVA grafting yield and imaging of fiber surfaces after grafting. Grafting 
yield indicates the PVA grafting technique can be altered using glutaraldehyde 
concentration and immersion time to control the degree of PVA-grafted onto UHMWPE 
fiber surfaces. Experimentally, aldehyde functionalization of fibers was critical in order 
to facilitate PVA grafting where no significant grafting yield was observed for samples 
not immersed in glutaraldehyde solution. Furthermore, SEM imaging showed the 
importance of oxygen-containing groups on the fiber surfaces for successful grafting, 
where samples not subjected to plasma treatment did not indicate any signs of aldehyde 
functionalization after immersion in glutaraldehyde. Together, these two studies confirm 
the theoretical reaction scheme proposed in Figure 5.5b depicting glutaraldehyde as a 
covalent linkage between UHMWPE and PVA.   
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PVA grafting was performed to increase UHMWPE-PVA interfacial adhesion. Adhesion 
was quantified using single UHMWPE fiber pull-out. It is interesting to note that both the 
debonding force and the frictional force measured during fiber pull-out increased 
following PVA grafting. Higher frictional loading following grafting could be indicative 
of increased fiber surface roughness that allows for mechanical interlocking as the fiber is 
pulled out of the hydrogel.  
 
Fiber pull-out testing indicates interfacial shear strength can be tailored using oxygen 
plasma treatment time, as well as glutaraldehyde concentration and immersion time. In 
general, depending on grafting conditions, interfacial shear strength was observed to 
increase from 11.5 ± 2.9 kPa without any treatment to 228.6 ± 77.1 kPa after PVA 
grafting. The dependence of interfacial shear strength on plasma treatment time for PVA-
grafted samples indicates a limiting factor for adhesion based on the number of sites 
created during plasma treatment. Furthermore, dependence as a function of grafting 
conditions shows grafting efficiency can be tailored. Similar trends were observed 
between grafting yield and interfacial shear strength as a function of PVA grafting 
conditions, where low concentrations (5 wt% glutaraldehyde) were more dependent on 
grafting immersion time and high concentrations (20 wt% glutaraldehyde) reached 
maximum efficiency after two hours of aldehyde grafting. As a whole, Figure 5.15 and 
5.16 showcases the ability of this system to be tailored in respect to both the number of 
active sites for grafting on the fiber surface and the percentage of sites that are utilized. 
High standard deviations in IFSS values, particularly for chemically grafted samples, 
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were noted and could result from variations in residual stresses formed during sample 
preparation. 
 
In some cases, UHMWPE fibers were observed to fail in tension during fiber pull-out 
testing. This indicates cases in which the interfacial shear strength exceeds that of the 
fiber tensile strength. Honeywell reports UHMWPE fiber tensile strength to be 3.25 GPa. 
Maximum fiber stress calculations during fiber pull-out testing for grafted samples 
further corroborate this theory, as they are similar in value to reported UHMWPE tensile 
strength. The observed fiber failure is an indication that the full potential of the fibers is 
being utilized through successful stress transfer from the fiber to the matrix following 
PVA grafting.  
 
Inter-fiber spacing was found to impact interfacial shear strength as shown in Table 5.3 
for PVA-grafted fibers. No impact was observed for non-grafted UHMWPE fibers, most 
likely due to poor initial interfacial properties. For grafted samples, interfacial shear 
strength increased with fiber spacing. This result was expected, as the large Ef/Em ratio 
for this material would indicate fiber stress transfer to the matrix would occur over a 
relatively large distance. Of note, for fiber pull-out tests using three fibers, interfacial 
shear strength results were divided by the number of fibers; however, failure did not 
necessarily occur simultaneously for all three fibers. In fact, macroscopically initial 
debonding was typically observed for a single fiber. This observation is further 
corroborated by comparing fiber pull-out testing using thee fibers (spacing = 1 mm) 
without the correction, 181.5 ± 60.6 kPa, to single fiber pull-out testing, 228.6 ± 77.1 kPa, 
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where results are not statistically significant (p > 0.05). Three fibers with no inter-fiber 
spacing without the correction remained statistically significant from single UHMWPE 
fiber results further indicating the importance of inter-fiber spacing for optimizing 
interfacial stress transfer (p < 0.05). Interestingly, fiber bundles obtained from the 
manufacturer (60 individual fibers) had significantly high interfacial shear strength values 
even after correction without any PVA grafting compared to other fiber formations tested. 
This result is indicative of very high mechanical interlocking resulting from the large 
number of single fibers present within a bundle during testing. 
 
All of the interfacial adhesion experiments detailed in this report were performed using 
single or bundled UHMWPE fibers. The effectiveness of various surface treatments on 
interfacial shear strength may be impacted using fiber mats or 3D fiber geometries. The 
influence of fiber orientation and layout on interfacial properties was not evaluated.   
 
During fiber pull-out testing, failure will occur at the weakest point. This can include 
cohesively within the fiber, at the fiber-matrix interface, or cohesively within the 
hydrogel. Due to poor adhesion between PVA and UHMWPE fibers, failure was 
expected to occur at the PVA-UHMWPE interface. This was proven using SEM for non-
chemically grafted fibers, where failure was noted at the interface. SEM images after 
fiber pull-out indicated cohesive shear failure within the hydrogel matrix for PVA-g-
UHWMPE samples. This observation is another indication that the PVA-UHMWPE 
interface was successfully maximized for this system following chemical grafting.  
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PVA hydrogels were evaluated in shear to determine the maximum shear strength 
possible for UHMWPE-PVA composite materials. This is using the assumption that PVA 
shear stress and UHMWPE-PVA interfacial shear stress is the same at the interface.  
Results indicate 20 wt% PVA hydrogels synthesized with five freeze-thaw cycles have a 
shear strength of 1.42 ± 0.2 MPa. This hydrogel formulation was used for consistency 
with the hydrogel formulation used for fiber pull-out testing. This value is significantly 
higher than the observed UHMWPE-PVA interfacial shear strength following grafting, 
228.6 ± 77.1 kPa. The formation of a weaker “PVA interphase” between UHMWPE 
fibers and bulk freeze-thawed hydrogels could explain the mismatch between bulk PVA 
shear strength and the maximum interfacial shear strength observed. An interphase, area 
between the fiber and bulk hydrogel with unique properties, may result due to the 
grafting process where PVA is chemically cross-linked instead of physically cross-linked. 
 
As noted previously, the shear lag theory proposed by Cox [62] was based on linear 
elastic materials. PVA hydrogels, however, show a distinct hyperelastic response in shear 
(Figure 5.9). It should be noted that assuming linear elasticity when calculating interfacial 
properties is a significant limitation of the work presented. Furthermore, this could also 
explain why IFSS is significantly higher than PVA shear strength for composites that fail 
cohesively. Nonetheless, the conclusions drawn using the Cox model are still considered 
relevant as they are primarily used to draw comparisons between sample sets.  
 
Lastly, in vitro cytotoxicity was determined using a cell viability assay. This aspect was 
extremely important as excess glutaraldehyde remaining within the composite material 
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after grafting could result in cell death even at low concentrations [61]. As expected, poor 
cell viability was observed without washing (normalized cell count 0.06 ± 0.01). 
However, successful washing after 18 hours in water and an additional hour in ultrasound 
showed significantly improved cell viability (normalized cell count 0.97 ± 0.05). Of 
importance, ultrasound vibrations were necessary to remove glutaraldehyde from fibers 
and prevent cytotoxicity.  
 
5.6. Conclusions 
The interface of UHMWPE-PVA composites has been identified as a potential weakness. 
In this work, a novel biocompatible PVA grafting technique was successfully developed 
(Figure 5.5(b)) to create a covalent linkage at the UHMWPE-PVA interface and improve 
interfacial properties. PVA grafting yield and SEM imaging confirm the importance of 
both oxygen-containing groups on UHMWPE fibers surfaces and aldehyde 
functionalization for successful PVA grafting. Interfacial shear strength, measured using 
single fiber-pull out tests, further supported the importance of oxygen plasma treatment 
for successful grafting.  
 
UHMWPE-PVA interfacial shear strength was successfully increased from 11.5 ± 2.9 
kPa without any treatment to 228.6 ± 77.1 kPa after PVA grafting where both the number 
of active sites for grafting on the fiber surface and the percentage of sites that are utilized 
can be tailored using oxygen plasma treatment and various grafting conditions. Failure 
during fiber pull-out testing was observed to occur in shear, cohesively within the PVA 
hydrogel matrix. Shear strength analysis of bulk PVA hydrogels, however, is 
 156 
significantly higher than the observed shear strength during fiber pull-out indicating the 
presence of a weaker “PVA interphase” between UHMWPE fibers and the bulk PVA 
hydrogel. Cohesive failure indicates successful optimization of the UHMWPE-PVA 
interface.  
 
Spacing between fibers was observed to impact stress transfer at the UHMWPE-PVA 
interface. As expected, increased spacing resulted in higher observed interfacial shear 
strengths and more efficient stress transfer. Therefore, future composite designs should 
maximize inter-fiber spacing while maintaining appropriate interfacial shear strength for 
optimized stress transfer.   
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Figure 5.1: AFM images of 5×5 μm areas of UHMWPE monofilaments after (a) 0, (b) 2, 
(c) 4, (d) 6, (e) 8, and (f) 10 minutes of oxygen plasma treatment [46]. Vertical scale: 200 
nm.  
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Figure 5.2: Deconvoluted high resolution C1s spectra after (a) 0, (b) 2, (c) 4, (d) 6, (e) 8, 
and (f) 10 minutes of oxygen plasma treatment [46]. 
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Figure 5.3: (a) Shear testing experimental set-up. Hydrogel is shown in pink with blue 
arrows indicating direction of testing. Inset shows three-dimensional view of sample. (b) 
Failure was confirmed to occur in shear.  
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Figure 5.4: (a) Plasma reactor schematic [46]. (b) Optical image of plasma reactor. 
Sample is placed between electrodes (orange dashed lines). 
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Figure 5.5: (a) Reaction scheme detailing chemical cross-linking of PVA using an 
aldehyde-based cross-linking agent. Cross-linking results in the formation of an acetal 
bridge. (b) Theoretical reaction scheme for chemical grafting of PVA on plasma activated 
fibers using glutaraldehyde. 
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Figure 5.6: (a) Single UHMWPE fiber pull-out experimental set-up. (b) Schematic of 
fiber pull-out during testing. Fiber surface area in contact with hydrogel decreases as 
testing progresses.  
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Figure 5.7: Schematic detailing the fiber spacings tested (from left to right): single fiber, 
three individual fibers spaced in a triangular formation two mm apart, three fibers 
bundled together, fiber bundle (60 individual fibers) as received from manufacturer. Not 
drawn to scale.  
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Figure 5.8: Effect of glutaraldehyde concentration and exposure time on cell activity 
[61]. 
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Figure 5.9: Typical load vs. extension curve for PVA hydrogels loaded in shear. 
Hydrogels were prepared with 20 wt% PVA and five freeze-thaw cycles. 
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Figure 5.10: (a) Gross appearance of fiber mats without any PVA grafting (no coverage), 
some grafting (partial coverage), and maximum grafting (total coverage). (b) Grafting 
yield in the hydrated state of PVA-g-UHMWPE fibers as a function of glutaraldehyde 
(GA) concentration and exposure time.  
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Figure 5.11: SEM images of non-treated (0 min) and plasma treated (6 min) UHMWPE 
fibers following aldehyde functionalization. Surface roughening is only visible on plasma 
treated samples indicative of the need for oxygen-containing groups to be present on the 
fiber surface for grafting to be successful. 
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Figure 5.12: Effect of embedded length on interfacial shear strength after 0, 3, 6, and 9 
minutes of plasma treatment.  
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Figure 5.13: Typical load vs. extension curves during single fiber pull-out for PVA-g-
UHMWPE and plasma treated UHMWPE fibers showing initial debonding followed by 
friction loading. 
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Figure 5.14: Interfacial shear strength as a function of plasma treatment time for both 
PVA-g-UHMWPE fibers and non-grafted fibers. PVA-g-UHMWPE fibers were grafted 
using 20 wt% glutaraldehyde for six hours. 
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Figure 5.15: Interfacial shear strength as a function of glutaraldehyde concentration. 
Samples were immersed in glutaraldehyde for two hours. Orange data points indicate 
fiber failure in tension and were not included in average. Bar indicates average interfacial 
shear strength. 
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Figure 5.16: Interfacial shear strength as a function of glutaraldehyde immersion time. 
Samples were immersed in 5 and 20 wt% glutaraldehyde. Orange data points indicate 
fiber failure in tension and were not included in average. Bar indicates average interfacial 
shear strength. 
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Figure 5.17: SEM micrographs of UHMWPE fiber surfaces after fiber pull-out testing 
for (a) non-grafted and (b) PVA-g-UHMWPE fiber samples. Both samples were treated 
with oxygen plasma for six minutes. 
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Figure 5.18: Cell count normalized to control cell count (PBS sample) as a function of 
extract release time where fiber samples were placed in PBS and PBS was extracted at 1, 
2, and 3 days. This is shown for samples subjected to 0, 2, 6, and 18 hours of washing 
and one hour of washing under ultrasound. 
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Figure 5.19: Cell count normalized to control cell count (PBS sample) as a function of 
wash time (0,2,6, or 18) in hours. This is based on sample extracts from fibers after one 
day in PBS. Samples with ultrasound were subjected to an additional wash step for one 
hour under ultrasound. 
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Table 5.1: Summary of plasma reactor specifications.  
 
Plasma Reactor Specifications 
Power Output 20-30 W 
Frequency ~ 1 kHz 
Dielectric Quartz 
Power Source Pulsed 
Electrode area 0.03 m
2
 
Gap Distance 2 mm 
Flow Rate 1 LPM O2 
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Table 5.2: Summary of interfacial shear strength values as a function of 
plasma treatment time with and without PVA grafting. 
 
Plasma  
Treatment  
Times 
Interfacial Shear Strength (kPa) 
Without PVA Grafting With PVA Grafting* 
0 min 11.47 ± 2.9 35.7 ± 19.6 
3 min 16 74 ± 5.0 137.1 ± 42.8 
6 min 27.41 ± 5.0 228.6 ± 77.1 
 
          * PVA grafting performed using 20 wt% glutaraldehyde for six hours. 
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Table 5.3: Summary of interfacial shear strength as a function of fiber 
spacing with and without PVA grafting.  
 
Fiber Pull-Out  
Test 
Interfacial Shear Strength (kPa) 
Without PVA Grafting With PVA Grafting** 
Multiple (Spacing = 0 mm) 18.9 ± 9.6 35.9 ± 12.8 
Multiple (Spacing = 1 mm) 12.8 ± 8.3 60.5 ± 20.2 
Single (Spacing = ∞) 11.47 ± 2.9 228.6 ± 77.1 
Bundle* 86.9 ± 35.2 106.0 ± 30.7 
 *Bundle as received from manufacturer (60 individual fibers). 
 ** PVA grafting performed using 20 wt% glutaraldehyde for six hours. 
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Chapter 6: Evaluate the performance and biocompatibility of fiber-reinforced 
hydrogels as meniscal replacements 
 
6.1. Introduction 
The native meniscus is a biologic composite of collagen fibers and extracellular matrix. 
The location and orientation of fibers within the meniscus directly contributes to the 
anisotropic mechanical properties observed [1-4]. As a result, synthetic fiber-reinforced 
composite materials are an obvious material choice to replicate the property distribution 
within the native meniscus. Mimicking the mechanical property distribution of the 
meniscus is essential for restoring the contact pressures along the tibial plateau during 
gait and preventing the onset of osteoarthritis following injury. Toward this purpose, the 
material presented in this work is a novel composite material that combines a hydrogel 
capable of replicating the compressive properties of the meniscus and fibers capable of 
resisting the hoop stresses that occur circumferentially in the meniscus. The goal of this 
aim was to evaluate the proposed fiber-reinforced hydrogel composite as a total meniscus 
replacement, especially regarding feasibility, biocompatibility, and material choice. 
Novel characterization techniques utilizing an in vitro knee simulator developed by the 
Hospital of Special Surgery were used to evaluate the implant design [5,6].  
 
The research performed in this aim also addresses the fundamental issue: What factors 
are important in controlling the mechanical and physiological properties of fiber-
reinforced composites? Fiber-reinforced polymer composites have not been used 
extensively for soft tissue applications in the body [7]. Determination of the important 
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factors for adequate performance of these materials in vivo will be important for future 
research in this field and in designing new materials. Additionally, the composite 
proposed within this work is unique in that it incorporates two materials with vastly 
different mechanical properties. Typical composites have an Ef/Em in the range of 10
1 
to 
10
3
 [8-11]; however, the proposed material has an Ef/Em in the range of 10
5
 to 10
6
. The 
analysis of this material will provide information about a potential new class of 
biomaterials, which can be used towards the development of numerous tissue 
replacements, including fibrocartilage, articular cartilage, tendons, and ligaments. All of 
these tissues are prone to injury, tend to have limited healing capacity, and are associated 
with osteoarthritis following injury [12-16].  
 
In this work, physically cross-linked poly(vinyl alcohol) (PVA) hydrogels were 
reinforced with ultra high molecular weight polyethylene (UHMWPE) fibers. The tensile 
modulus was determined as a function of fiber volume fraction. Composites were 
manufactured using resin transfer molding in the shape of the native meniscus. 
Evaluation was performed both in vitro, using a knee gait simulator, and in vivo, using a 
sheep model. Both of these studies were performed in collaboration with the Hospital of 
Special Surgery in New York City. 
 
6.2. Materials and methods 
6.2.1. Composite preparation 
6.2.1.1. Tensile samples 
PVA hydrogels were reinforced using UHMWPE fibers with a fiber diameter of 
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approximately 25 μm from Fiber Materials, Inc. (Biddeford, ME). Fibers were obtained 
under trade name Spectra® 1000 in plain weave style 945 with a denier of 215 and a 
reported fiber modulus of 113 GPa. Fibers were treated with oxygen plasma for six 
minutes at 1.00 SLPM O2 (see section 5.3.4).  
 
UHMWPE fiber mats were aligned without bias and, due to the plain weave geometry of 
the fabric, no special care was taken to differentiate between warp and weft directions. 
Composites were prepared using a wet lay-up process by impregnating UHMWPE fiber 
mats with polymer solution before placing them between two microscope glass slides 
with a Teflon spacer and securing the assembly with binder clips. Depending on the 
amount of hydrogel solution needed to fill sample volume, additional solution was added 
as needed. No special steps were required to place or ensure that the fiber mats remained 
in the middle of the composite. Polymer solutions with 20 wt% PVA/PVP were prepared 
as described previously in section 4.3.1. The mold was subjected to 21 hours of freezing 
at -20°C and 3 hours of thawing at room temperature for up to six cycles. The fiber 
volume fraction for each sample was controlled using a constant thickness Teflon spacer, 
1.5 mm, and varying the number of fiber mats placed within the spacer from two to six 
layers of UHMWPE. Various polymer concentrations and freeze-thaw cycles were also 
evaluated; however, a significant effect was not observed (data not shown).   
 
6.2.1.2. Implants 
The overall synthesis and implantation procedure for UHMWPE-PVA composites is 
shown in Figure 6.1. Total meniscus replacements were manufactured using low-pressure 
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resin transfer molding. Molds were designed and produced by Joe Lipman from the 
Hospital of Special Surgery based on geometries extracted from magnetic resonance 
imaging (MRI) of a sheep knee. This technique allows for patient-specific implants 
matching the size and shape of the patient’s native meniscus. For this work, however, the 
sheep were not identified in advance to allow for specific molds to be manufactured.  
 
Polymer solution with approximately 25 wt% PVA/PVP was prepared as described 
previously in section 4.3.1. This polymer concentration was chosen based on swelling 
results (see section 4.4.4) and is described in more detail in the discussion section of this 
chapter. As stated previously, polymer concentration was not observed to have an impact 
on composite tensile modulus. UHMWPE fibers were treated with oxygen plasma 
treatment for six minutes at 1.00 SLPM O2 (see section 5.3.4). UHMWPE fiber mats 
were impregnated with PVA solution and aligned within the mold, such that either the 
warp or weft was aligned circumferentially. Circumferential alignment of fibers was 
desired to mimic the natural alignment of collagen fibers in the native meniscus [1,2,17]. 
Longer fiber strips were also arranged circumferentially and allowed to exit the outlet 
ports at the posterior and anterior horns to serve as tie fibers for fixation. Once the fibers 
were arranged, the mold was sealed using a c-clamp, and PVA solution was injected until 
a steady stream was seen exiting the outlet ports. An image depicting typical fiber lay-up 
within the mold is shown in Figure 6.1(c). The estimated fiber volume fraction was 
approximately 35-50%. High fiber volume fractions were necessary to ensure fibers were 
equally dispersed throughout the sample. The mold was subjected to 21 hours of freezing 
at -20°C and 3 hours of thawing at room temperature for six cycles. 
 188 
 
6.2.2. Tensile modulus 
The tensile modulus was measured using a bench top mechanical testing machine using 
rectangular specimens of the composites. Due to the strength of the UHMWPE fibers, 
UHMWPE-PVA composites were specially cut using electric shears to avoid damaging 
the composite. UHMWPE-PVA samples were sectioned without a bias, and because of 
the plain weave geometry of the fabric, no special care was taken to differentiate between 
warp and weft during sectioning. Each sample was subjected to 15% strain at a strain rate 
of 10% per min. UHMWPE-PVA composites were tested on an Instron Materials Testing 
System Series 8872 (Norwood, MA) with a 1 kN load cell and an approximate sample 
size of 12 mm in width, 1.5 mm in thickness, and 30 mm in gauge length (n = 4). 
Additionally, sandpaper on the grip surfaces was used to increase effectiveness of the 
tensile grips. The tests were monitored to ensure that slipping did not occur within the 
first 10% strain. The tensile modulus was calculated from the slope of the linear portion 
in the stress vs. strain curve. 
 
6.2.3. Environmental SEM 
Environmental scanning electron microscopy (SEM; FEI Quanta 600, Hillsboro, OR) 
operated at a voltage of 10 kV was used to image hydrated UHMWPE-PVA composite 
cross-sections and was performed by personnel at the Hospital of Special Surgery. 
 
6.2.4. Knee simulator 
An in vitro sheep knee model was used to evaluate the performance of UHMWPE-PVA 
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meniscal composites through collaboration with the Hospital of Special Surgery. The 
methods used have been described in detail previously [5,6]. Briefly, an Instron-Stanmore 
KC Knee Joint Simulator (University College London, Middlesex, United Kingdom) was 
used to apply physiological loads to cadaveric sheep knees. The equipment set-up is 
shown in Figure 6.2. Axial force, flexion angle, anterior force, posterior force, and 
rotational moment were varied as a function of gait based on a previously published 
modified sheep gait profile [6]. The axial force and flexion angle programmed into the 
simulator is shown in Figure 6.3 [6]. Anterior-posterior force and internal-external 
rotation was also controlled.  
 
Fresh-frozen cadaveric sheep knees were acquired from Tom Schaer (n=6). Extraneous 
soft tissue was removed, including skin, fat, muscle, and the patella. The knees were 
potted into the machine using poly(methyl methacrylate) bone cement. Normal contact 
stresses and areas were measured using a 4010 N Tekscan® pressure sensor (Boston, 
MA) placed on the surface of the tibial plateau. Test conditions included: an intact 
meniscus, total meniscectomy, allograft replacement, and UHMWPE-PVA implant 
replacement. An orthopedic surgeon, Florian Wanivenhaus, performed the surgeries 
using clinically accepted procedures. UHMWPE-PVA samples were surgically implanted 
using methods similar to allograft transplantation. The tie-in fibers at the posterior and 
anterior horns of the implants were used for fixation through bone tunnels, and sutures 
were applied along the periphery of the implant.  
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6.2.5. In vivo sheep model 
UHMWPE-PVA implants were also evaluated over the course of a four-month in vivo 
study using a sheep model (n=3). This study, however, is outside the scope of this report 
and will only briefly be mentioned to provide context for discussion regarding the focus 
of future efforts. The author was responsible for manufacturing the implants according to 
section 6.2.1.2, and the implants were implanted and evaluated by the Hospital of Special 
Surgery. The study was conducted at the University of Pennsylvania’s New Bolton 
Center.  
 
6.2.6. Statistical analysis 
All values are reported as means ± standard deviation for at least three independent 
samples. Statistical analysis was performed using a one-way analysis of variance 
(ANOVA) with a 95% confidence interval (p < 0.05) to compare mean values. 
 
6.3. Results 
6.3.1. Tensile modulus 
Tensile testing was performed on rectangular samples of PVA hydrogels reinforced with 
up to 29% volume fraction (Vf) UHMWPE. Typical stress versus strain curves showed a 
large toe region initially during extension, 3-4% strain, followed by linear elastic 
deformation as presented in Figure 6.4. The toe region observed is believed to be the 
result of initial slack present within the fiber mats during composite preparation. 
Interlaminar failure was noted at higher strains and resulted in failure. Tensile modulus 
was calculated from the slope of the stress vs. strain curve averaged over the linear region, 
 191 
i.e. the region following the initial toe region and prior to plastic deformation or failure, 
in the stress versus strain curve. This region is depicted in Figure 6.4 as a dashed line. In 
Figure 6.5 composite tensile modulus is plotted as a function of UHMWPE fiber volume 
fraction. A linear increase in modulus was observed as a function of Vf, with a tensile 
modulus of 90.6 ± 21.6 MPa and 258.1 ± 40.1 MPa at fiber volume fractions of 10% and 
29% UHMWPE respectively. Results indicate fibrous reinforcement is possible as a 
method of increasing tensile modulus to match that of the native meniscus, 94 to 295 
MPa [3], and other tissues of interest listed in Table 2.2. 
 
6.3.2. UHMWPE-PVA meniscal implants 
Total meniscus replacements were successfully prepared (Figure 6.6) and implanted 
(Figure 6.7) using the techniques described in section 6.2. Gross implant appearance was 
similar in size and shape to the native sheep meniscus. As depicted in Figure 6.8, 
environmental SEM images for cross sections of UHMWPE-PVA meniscal implants 
using plasma treated fibers indicate good dispersion of the fibers throughout the sample. 
Voids are visible, however, between UHMWPE fibers and the hydrogel. 
 
6.3.3. Knee simulator 
UHMWPE-PVA implants were evaluated in vitro using a sheep knee simulator. Typical 
contact pressures and areas along the tibial plateau are shown in Figure 6.9 for an intact 
meniscus, after meniscectomy, allograft transplantation, and UHMWPE-PVA 
implantation. Red denotes areas of high contact stress, blue areas of low stress, and black 
no loading. For cases with an intact meniscus, well-dispersed uniform loading was noted. 
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Following total meniscectomy significant decreases in contact area and increases in 
contact stress were noted consistent with literature reports documenting the effect of 
meniscectomy [18]. Contact stress distribution improved after both allograft 
transplantation and UHMWPE-PVA implantation; however, neither treatment restored 
the contact pressure distribution to that of the native meniscus.  
 
Quantification of the average contact area and maximum contact stress measured during 
testing are shown in Figure 6.10 and Figure 6.11 respectively. Statistically significant 
improvements in average contact area were observed after UHMWPE-PVA implantation 
compared to a total meniscectomy (p < 0.05). No statistical significance on maximum 
contact pressure was noted after allograft transplantation or UHMWPE-PVA 
implantation compared to a meniscectomy. It is important to note that maximum contact 
stress is not representative of the contact pressure distribution experienced during gait but 
is the single highest contact pressure experienced.  
 
6.3.4. In vivo sheep model 
UHMWPE-PVA implants were also evaluated in vivo using a sheep model. Although this 
study is outside the scope of this report, a brief documentation of the results is included 
for discussion purposes. Of the three UHMWPE-PVA composites implanted, no evidence 
was noted indicating biocompatibility issues. Two of the three cases were completely 
weight bearing by the end of the study. One case was only 60-70% weight bearing after 
four months due to the patella moving out of place. MRI results (Figure 6.12) indicated 
implant extrusion and bone tunnel widening. Significant delamination between 
 193 
UHMWPE fibers (Figure 6.13) was also noted in two of the three cases. Tissue ongrowth 
was observed in all cases. In Figure 6.14, an UHMWPE-PVA implant is shown after 
removal from the knee joint. No implants showed any signs of significant changes in 
volume. Major cartilage damage was present in two of three knees corresponding to the 
cases where significant implant failure occurred. Only minor cartilage damage was 
present in the knee where the implant remained mostly intact.  
 
6.4. Discussion 
Fibrous reinforcement of PVA hydrogels was performed using UHMWPE fibers. The 
results indicate that fibrous reinforcement is possible as a method of increasing tensile 
modulus to match that of the native meniscus. UHMWPE-PVA composites exhibit 
similar tensile stiffness to that seen in the native meniscus in the circumferential direction, 
94–295 MPa [3]. The axial elastic modulus of UHMWPE fibers is very high (113 GPa), 
such that composite modulus values, calculated based on simple rule-of-mixtures 
calculations, assuming that only half of the UHMWPE fiber volume contributed to the 
tensile modulus in the direction of testing due to the fiber arrangement within the 
UHMWPE fiber weaves, are much higher than were measured. The equation used for 
predication is shown in Equation 6.1, where Em, Ec, and Ef are the elastic moduli for the 
matrix, composite and fiber, respectively: 
 
   (    )   
 
 
      (6.1) 
 
Using this model, the predicted modulus was 5.8 and 16.4 GPa for 10% and 29% 
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UHMWPE fiber volume fractions, respectively. These predicted values are almost two 
full orders of magnitude larger than experimental values. Poor stress transfer between 
UHMWPE fibers and the PVA hydrogel is a possible explanation for the low composite 
modulus observed.  
 
Environmental SEM images show the presence of voids between UHMWPE fibers and 
the PVA hydrogel. Although it is possible the voids are formed during fracture formation, 
this observation is likely indicative of poor interfacial properties. As Aim 3 was 
conducted concurrently with Aim 2, only oxygen plasma treatment was used to increase 
UHMWPE-PVA interfacial adhesion. The IFSS results, however, clearly demonstrate the 
importance of PVA chemical grafting onto UHMWPE fiber surfaces for maximum 
adhesion. Chemical grafting resulted in IFSS increases of up to 228.6 ± 77.1 kPa 
compared to IFSS values of 27.41 ± 5.0 kPa after plasma treatment and 11.5 ± 2.9 kPa 
without any treatment. The discrepancy between predicted and experimental composite 
tensile modulus and the presence of voids at the UHMWPE-PVA interface provide 
further evidence of poor stress transfer at the UHMWPE-PVA interface without PVA 
grafting. 
 
UHMWPE-PVA meniscus implants were successfully manufactured and implanted 
illustrating the feasibility of the proposed material. In vitro results are promising, 
indicating comparable contact pressure distributions to allograft transplantation. Allograft 
transplantation is currently the only FDA approved treatment for total meniscal 
replacement. Allograft use in the clinical is low, however, due to limited availability, cost, 
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and the possibility of transferring diseases [19,20]. No partial meniscal replacement is 
currently FDA approved. Thus, there is a significant clinical need to develop materials to 
serve as either partial or total meniscal replacements. Neither allograft transplantation nor 
UHMWPE-PVA implantation, however, was able to replicate the native contact pressure 
distribution.  
 
Three UHMWPE-PVA composites were also successfully implanted in vivo using a 
sheep model. In vivo swelling behavior was a significant concern due to high swelling 
pressures present in load bearing joints. Specific Aim 1 focused on characterizing 
hydrogel swelling as a function of polymer composition, freeze-thaw cycling, and in vitro 
solution osmotic pressure. Especially in the case of composite biomaterials, controlling 
swelling behavior is necessary to minimize the formation of residual stresses at the fiber-
matrix interface. Results indicated minimal volume changes were observed for 20 and 
30-35 wt% PVA for osmotic pressures of 0 and 0.95 atm respectively. The swelling 
pressure for articular cartilage has been reported to range from 0.3 to 2.5 atm [21,22]; 
however, the meniscus has a significantly lower proteoglycan content then articular 
cartilage contributing to a lower swelling pressure range. The exact swelling pressure 
range has not been documented to date. In order to account for these factors, implants 
were manufactured with 25 wt% PVA. In vivo results did not show any evidence of 
implant changes in volume validating polymer concentration selection.  
 
Bone tunnel widening in vivo was likely a result of mechanical wear due to movement of 
UHMWPE tie-in fibers within the bone tunnels over the course of the study. This 
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observation is indicative of poor fixation and may have adversely impacted composite 
performance. Inadequate fixation can also be a contributing factor for the poor contact 
pressures observed in vitro compared to the intact meniscus. Good fixation is required to 
successfully transfer stress from the femur to the tibia during gait. The best method for 
fixation of the implant needs to be determined; however, surgical implantation and 
techniques are outside the author’s expertise. The ideal fixation method would encourage 
integration into the bone at the posterior and anterior horns of the implant replicating the 
fixation of the native meniscus. In some cases, allograft transplantation techniques use 
bone plugs and bridges to encourage integration with bone [23,24]. Similar techniques 
can be employed to provide improved fixation for UHMWPE-PVA implants as well.  
 
The implant design used for this work was rudimentary and severely limited by the 
materials (UHMWPE fiber mats) and available processing techniques (manual fiber lay-
up and orientation) available. Non-ideal fiber orientation and distribution resulted in 
delamination in vivo and contributed to implant extrusion. Using a three-dimensional 
UHMWPE fiber weave, versus the use of fiber layers, would likely prevent delamination 
and extrusion. PVA chemical grafting onto UHMWPE fiber surfaces would further 
improve stress transfer within the composite material. Interestingly, the specific in vivo 
case showing minimal implant failure also presented minimal signs of osteoarthritis. This 
result further indicates the importance of using precise fiber orientation and maximum 
fiber-hydrogel stress transfer to prevent implant failure and subsequently the onset of 
osteoarthritis in vivo.  
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As displayed in this work, maximizing stress transfer at the fiber-matrix interface is 
critical in controlling the material’s mechanical properties and improving implant 
performance. Therefore, careful optimization of the processing parameters discussed in 
the previous chapters needs to be performed in order to maximize stress transfer and 
corresponding material properties. This includes parameters such as: fiber treatment 
conditions, fiber spacing, and hydrogel formulation. Additionally, improved stress 
transfer would allow for lower UHMWPE fiber volume fractions corresponding to 
increased spacing between individual fibers compared to composites with relatively poor 
stress transfer. As discussed previously, increased spacing between fibers would also 
result in further improvements to stress transfer at the fiber-matrix interface.  
 
6.5. Conclusion 
Poor mechanical properties are a serious limitation for both degradable scaffolds and 
natural materials used as meniscal replacements [20]. Mimicking the property 
distribution of the human meniscus is crucial in restoring the native contact pressures 
during gait and prevention of osteoarthritis. A non-degradable anisotropic material as 
described in this work, however, has the potential to mimic the property distribution 
within the meniscus. An investigation of composite mechanical properties indicates fiber-
reinforced PVA hydrogels may be able to replicate the anisotropic modulus distribution 
present in the native meniscus through controlled fiber placement and material processing. 
Fibrous reinforcement of hydrogels increased the tensile modulus from 0.23 ± 0.02 MPa 
without any reinforcement to 258.1 ± 40.1 MPa with 29% UHMWPE. The tensile 
modulus of the human meniscus can range from 2 to 295 MPa [25]. In vitro gait 
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simulation studies using a sheep model show similar contact pressure distributions after 
UHMWPE-PVA implantation compared to allograft transplantation. Implants were also 
implanted in vivo successfully using a sheep model for four months. No signs of implant 
swelling or issues regarding biocompatibility were noted. Fiber orientation and 
distribution, as well as, implant fixation were found to contribute significantly to implant 
performance and will be a focus for future work.  
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Figure 6.1: Schematic detailing UHMWPE-PVA synthesis and implantation procedure. 
(a) MRI images were used to extract the (b) native meniscus geometry and produce (c) 
resin transfer molding for implant synthesis. (d) UHMWPE-PVA meniscal replacements 
were (e) implanted similarly to allografts using bone tunnels and suturing for fixation 
[26]. 
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Figure 6.2: Typical knee gait simulation experimental set-up showing femoral and tibial 
potting block, flexion/extension axis of rotation, and tibial contact pressure sensor. 
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Figure 6.3: Simulator inputs for axial force and flexion/extension angle as a function of 
gait for two cycles [6].  
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Figure 6.4: Typical stress vs. strain curve for 10% Vf UHMWPE-PVA composite 
following five freeze–thaw cycles in tension. The dashed line represents the linear region 
of the curve used to calculate the tensile modulus.  
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Figure 6.5: The tensile modulus of UHMWPE-PVA composites increases linearly with 
fiber volume fraction within the range of native meniscus. 
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Figure 6.6: Optical comparison between UHMWPE-PVA implant and native sheep 
meniscus. Scale bar in cm.  
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Figure 6.7: UHMWPE-PVA composite implanted in sheep cadavers. (a) Top view 
during trial sheep implantation. (b) Front view during knee simulation testing detailing 
femur potting block and contact pressure sensor.  
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Figure 6.8: Environmental SEM micrographs of the cross-section of an UHMWPE-PVA 
meniscal implant with plasma treated fibers. Good dispersion of the fibers throughout the 
sample is noted. 
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Figure 6.9: Typical contact pressures along the tibial plateau are shown for an intact 
meniscus, meniscectomy, allograft, and UHMWPE-PVA implant. Red denotes areas of 
high stress, blue for areas of low stress, and black is zero loading. 
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Figure 6.10: Average contact area along the tibial plateau measured during gait 
simulation using a sheep model. *UHMWPE-PVA implantation resulted in a significant 
increase in contact area compared to meniscectomy. **Higher contact areas were 
observed for intact menisci compared to all treatment options. (p < 0.05) 
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Figure 6.11: Average maximum pressure along the tibial plateau measured during gait 
simulation using a sheep model. No statistically significant differences were observed 
between meniscectomy, allograft, and UHMWPE-PVA implant treatments. 
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Figure 6.12: Anterior view of a sheep knee four months after in vivo UHMWPE-PVA 
implantation. MRI indicates bone tunnel widening and implant extrusion.   
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Figure 6.13: Gross appearance of UHMWPE-PVA implant (left) after four months in 
vivo using a sheep model. Delamination between UHMWPE fiber layers was observed. 
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Figure 6.14: Gross appearance of UHMWPE-PVA implant after removal following four 
months in vivo using a sheep model. No significant implant volume change noted. 
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Chapter 7: Conclusions and Recommendations for Future Work 
 
7.1. Conclusions 
The objective of this work was to design a novel composite material that combines a soft 
poly(vinyl alcohol) (PVA) hydrogel capable or replicating the compressive properties of 
the meniscus and strong ultra high molecular weight polyethylene (UHMWPE) fibers, 
capable of resisting the hoop stresses that occur circumferentially within the meniscus.  
 
The compressive modulus of PVA freeze-thawed hydrogels varied between 0.0012 ± 
0.0005 and 0.85 ± 0.04 MPa, similar to the aggregate compressive modulus values 
reported for meniscal, articular, and TMJ cartilage. Furthermore by comparing aged and 
freeze-thawed physically cross-linked hydrogels, two separate mechanisms were 
discovered to occur, namely crystallization and phase separation, each of which 
contributed to hydrogel modulus independently. Crystallization occurred at early freeze-
thaw cycles (1-3 cycles) and phase separation and PVA densification occurred at later 
cycles (3-6 cycles). This research provides information into the mechanisms that occur 
during gelation and can be used to design hydrogels with very specific properties 
(porosity, modulus, crystallinity, etc) for various applications. 
 
Further evaluation of PVA hydrogels was performed in vitro using osmotic pressure 
solutions to mimic the swelling pressure in the knee. This study was particularly relevant, 
as typical in vitro swelling studies use non-osmotic solutions. The importance of 
replicating swelling pressure in vitro was demonstrated, with all hydrogel formulations 
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experiencing decreases in equilibrium hydration in osmotic solution compared to non-
osmotic solution. Hydrogels with a polymer concentration of 20 wt% PVA experienced 
limited swelling in vitro in non-osmotic solution (0 atm), while higher polymer 
concentrations were required, between 30 and 35 wt% PVA, for limited swelling in 
osmotic solution (0.95 atm). No significant effect on swelling ratio was discerned with 
freeze-thaw cycles (p > 0.05) This result impacts design considerations, allowing the 
tailoring of PVA hydrogels through modulation of polymer concentration and freeze-
thaw cycles to independently achieve a specific swelling ratio and compressive modulus. 
In general, PVA hydrogels were shown to be extremely tailorable over a wide range of 
properties, indicating their usefulness for soft tissue applications. 
 
The interface between UHMWPE fibers and the PVA hydrogel was identified early on as 
a potential weakness in the development of the composite. To improve interfacial 
adhesion, a novel biocompatible PVA grafting technique was successfully developed to 
create a covalent linkage at the UHMWPE-PVA interface and improve interfacial 
properties. PVA grafting yield and SEM imaging confirmed the importance of both 
oxygen-containing groups on UHMWPE fiber surfaces and aldehyde functionalization 
for successful PVA grafting. Additionally, this technique can be adapted to other fiber 
materials, allowing for a wide range of fiber-based PVA hydrogel composites.  
 
Fiber pull-out tests were used to characterize interfacial adhesion. UHMWPE-PVA 
interfacial shear strength was successfully increased from 11.5 ± 2.9 kPa without any 
treatment to 228.6 ± 77.1 kPa after PVA grafting. Further, control of both the number of 
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active sites for grafting on the fiber surface and the percentage of sites utilized was 
demonstrated by varying oxygen plasma treatment and grafting conditions. Failure during 
fiber pull-out testing was observed to occur cohesively within the PVA hydrogel matrix, 
indicating successful optimization of the UHMWPE-PVA interface.  
 
Spacing between fibers was also observed to impact stress transfer at the UHMWPE-
PVA interface. As expected, increased spacing resulted in higher observed interfacial 
shear strengths and more efficient stress transfer. Therefore, future composite designs 
should maximize inter-fiber spacing for optimized stress transfer. Of note, a majority of 
the models used in this work were based on materials that behave linear elastically. The 
composite presented, however, does not. A non-linear model should be developed to 
allow for more accurate behavior predication and improved optimization. 
 
Poor mechanical properties are a serious limitation for both degradable scaffolds and 
natural materials used as meniscal replacements. Mimicking the property distribution of 
the human meniscus is crucial in restoring the native contact pressures during gait and 
prevention of osteoarthritis. A non-degradable anisotropic material as described in this 
work, however, has the potential to mimic the property distribution within the meniscus. 
An investigation of composite mechanical properties indicates fiber-reinforced PVA 
hydrogels may be able to replicate the anisotropic modulus distribution present in the 
native meniscus through controlled fiber placement and material processing. Fibrous 
reinforcement of hydrogels increased the tensile modulus from 0.23 ± 0.02 MPa without 
any reinforcement to 258.1 ± 40.1 MPa with 29% UHMWPE. In vitro gait simulation 
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studies using a sheep model show similar contact pressure distributions after UHMWPE-
PVA implantation compared to allograft transplantation. Composites were also implanted 
in vivo successfully using a sheep model for four months. No signs of implant swelling or 
issues regarding biocompatibility were noted. Fiber orientation, fiber distribution, and 
implant fixation were found to contribute significantly to implant performance and will 
be a focus for future work.  
 
7.2. Recommendations 
The work presented can serve as a basis for improved material design. Recommendations 
for future work include: 
 Controlling fiber orientation using three-dimensional weaves for anisotropic 
property distribution that replicates the native meniscus. 
 Design fixation methods that integrate the composite into native tissue for more 
physiologically relevant fixation. 
 Determine effect of fiber orientation and volume fraction on implant performance. 
 Develop models to account for nonlinear material behavior and allow for 
optimization of various processing parameters.  
 Evaluate implant performance using PVA-grafted UHMWPE fibers. 
 Adapt current research to design other synthetic replacement tissues, including 
ACL and annulus fibrosus.  
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